Source	Contributors	VarID	Variable	Value	Description	Meta	Level	CellTissue	TissueContext	Complex	Dimensions	IndividualLevelData	Entrez	CHEBI	MP	MPLabel	EFO	EFOLabel	VarWithinD	VarDvsCTRL	Relevance	Levels	Method	MethodCitation	MethodDetails	PrivateNote	Note	DataSource	DataSourceLink
PMID30232284	Vecchio et al. (2018)	Vecchio18_MPO.cells.tail	MPO.cells.tail	cells/mm2	Quantification of MPO-positive cells on FFPE pancreatic sections analyzed by IHC, number of cells per squared millimeter.	leukocyte infiltration	cell	neutrophil	pancreas	0	1	Yes	NA		MP:0002498	leukocyte infiltration				NA			immunohistochemistry	Vecchio et al. (2018)				Figure 2(C). Intact and NETting neutrophils infiltrate the pancreas of presymptomatic and symptomatic T1D donors.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237216/figure/F2/
PMID30232284	Vecchio et al. (2018)	Vecchio18_MPO.cells.head	MPO.cells.head	cells/mm2	Quantification of MPO-positive cells on FFPE pancreatic sections analyzed by IHC, number of cells per squared millimeter.	leukocyte infiltration	cell	neutrophil	pancreas	0	1	Yes	NA		MP:0002498	leukocyte infiltration				NA			immunohistochemistry	Vecchio et al. (2018)				Figure 2(C). Intact and NETting neutrophils infiltrate the pancreas of presymptomatic and symptomatic T1D donors.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237216/figure/F2/
PMID30203067	Capua et al. (2018)	Capua18_CXCL10.panH.score	CXCL10.panH.score	Score positive cell/field: 0: none; 1: ≤ 20; 2: 20-40; 3 :> 40	mRNA quantification (FISH) of CXCL10 in pancreas-head tissue	cytokines	transcript	pancreas	pancreas	0	1	Yes	NA		MP:0008713	abnormal cytokine level				NA			in-situ hybridization assay	Capua et al. (2018)	Viral RNA was visualized using the Quantigene ViewRNA technique based on branched DNA signal amplification technology, according to the manufacturer’s instructions (36). A probe set containing multiple oligonucleotides was used, designed to hybridize to the H1N1 pdm Cal and H1N1 pdm mouse-adapted viruses [NP gene; National Center for Biotechnology Information (NCBI) reference sequence AB538390]. To identify the cell types within islets, the following Quantigene probes were used: insulin for β cells (INS gene; NCBI reference sequence NM_000207), α-amylase 1 for exocrine cells (AMY1A gene; NCBI reference sequence NM_004038), and cytokeratin 19 for duct cells (KRT19 gene; NCBI reference sequence NM_002276). Quantification of cells positive for each probe was performed within eight randomly chosen fields using the IN Cell Investigator software (GE Health Care United Kingdom Ltd.).			Table 2. FISH for influenza viral RNA and CXCL10 RNA in human pancreases.	https://academic.oup.com/jcem/advance-article/doi/10.1210/jc.2018-00862/5091458
PMID30203067	Capua et al. (2018)	Capua18_CXCL10.panB.score	CXCL10.panB.score	Score positive cell/field: 0: none; 1: ≤ 20; 2: 20-40; 3 :> 40	mRNA quantification (FISH) of CXCL10 in pancreas-body tissue	cytokines	transcript	pancreas	pancreas	0	1	Yes	NA		MP:0008713	abnormal cytokine level				NA			in-situ hybridization assay	Capua et al. (2018)				Table 2. FISH for influenza viral RNA and CXCL10 RNA in human pancreases.	https://academic.oup.com/jcem/advance-article/doi/10.1210/jc.2018-00862/5091458
PMID30203067	Capua et al. (2018)	Capua18_CXCL10.panT.score	CXCL10.panT.score	Score positive cell/field: 0: none; 1: ≤ 20; 2: 20-40; 3 :> 40	mRNA quantification (FISH) of CXCL10 in pancreas-tail tissue	cytokines	transcript	pancreas	pancreas	0	1	Yes	NA		MP:0008713	abnormal cytokine level				NA			in-situ hybridization assay	Capua et al. (2018)				Table 2. FISH for influenza viral RNA and CXCL10 RNA in human pancreases.	https://academic.oup.com/jcem/advance-article/doi/10.1210/jc.2018-00862/5091458
PMID30203067	Capua et al. (2018)	Capua18_CXCL10.duodenum.score	CXCL10.duodenum.score	Score positive cell/field: 0: none; 1: ≤ 20; 2: 20-40; 3 :> 40	mRNA quantification (FISH) of CXCL10 in duodenum tissue	cytokines	transcript	duodenum	duodenum	0	1	Yes	NA		MP:0008713	abnormal cytokine level				NA			in-situ hybridization assay	Capua et al. (2018)				Table 2. FISH for influenza viral RNA and CXCL10 RNA in human pancreases.	https://academic.oup.com/jcem/advance-article/doi/10.1210/jc.2018-00862/5091458
PMID30203067	Capua et al. (2018)	Capua18_CXCL10.mean.score	CXCL10.mean.score	Score positive cell/field: 0: none; 1: ≤ 20; 2: 20-40; 3 :> 40	mRNA quantification (FISH) of CXCL10 averaged across available pancreas (head, body, tail) samples	cytokines	transcript	pancreas	pancreas	0	1	Yes	NA		MP:0008713	abnormal cytokine level				NA			in-situ hybridization assay	Capua et al. (2018)				Table 2. FISH for influenza viral RNA and CXCL10 RNA in human pancreases.	https://academic.oup.com/jcem/advance-article/doi/10.1210/jc.2018-00862/5091458
PMID30150306	Horwitz et al. (2018)	Horwitz18_beta.53BP1.prct	beta.53BP1.prct	%	Fraction of beta cells with activated 53BP1	aging markers; beta-cell heterogeneity	cell	type B pancreatic cell	islet of Langerhans	0	1	Yes	NA		MP:0010948	abnormal double-strand DNA break repair				NA	Activation of 53BP1 protein provides evidence for a beta-cell DNA damage response (DDR) in T1D; beta-cell DDR is more frequent in islets infiltrated by CD45+ immune cells, suggesting a link to islet inflammation.		immunostaining	Horwitz et al. (2018)	Paraffin sections were rehydrated, and antigen retrieval was performed in a decloaking chamber (Biocare Medical) in 50 mmol/L citrate buffer (pH 6). The following primary antibodies were used: guinea pig anti-insulin (1:400; DAKO), mouse antiglucagon (1:200; Abcam), rabbit anti-53BP1 (1:200; Bethyl), mouse anti-γ−H2AX Ser139 (1:3,000; Millipore), mouse anti-CD45 (1:100; DAKO), rabbit antiphosphorylated (phospho)-Kap1 (1:100; Bethyl), rabbit anti-p53 (1:400; Novocastra), rat anti-CD3 (1:300; Millipore), and rabbit anti–human growth hormone (hGH) (1:200; Abcam). Fluorophore-conjugated secondary antibodies used were donkey anti–guinea pig Alexa Fluor 488, donkey anti-rabbit Cy3/Cy5, and donkey anti-mouse Alexa Fluor 488/Cy3 (The Jackson Laboratory). DAPI (Invitrogen) was used as a nuclei marker. Horseradish peroxidase­–conjugated secondary antibody was donkey anti-rabbit (Histofine; Nichirei Biosciences). Diaminobenzidine (Lab Vision) was used as chromogen. Fluorescent images were taken with a Nikon C1 confocal microscope at 400× magnification. Bright-field images were taken with an Olympus BX53 at 400× magnification. Image quantification was performed using the ImageJ software.			Figure S1(D). The fraction of beta cells with activated 53BP1 in samples originating solely from the nPODrepository.	
PMID30078552	Gonzalez-Duque et al. (2018)	GonzalezDuque18_pan.MMr.IAPP	pan.MMr.IAPP	counts(x10-3) of Mmr+ cells/mm2 pancreas section area	MMr+ cells reactive for IAPP[15-17/5-10] antigen peptide in pancreas	autoreactivity	cell	CD8-positive, alpha-beta T cell	pancreas	0	1	Yes	NA							NA			immunohistochemistry	Culina et al. (2018)	In-Situ HLA-A2 MMr Staining In-situ immunohistochemistry staining was performed as described (Culina et al., 2018). Unfixed, frozen sections were dried for 2 h, loaded with 1 μg of PE-labeled MMrs overnight at 4°C, washed gently with PBS and fixed in 2% paraformaldehyde for 10 min. After a further wash, endogenous peroxidase activity was blocked with 0.3% H2O2. Sections were then incubated serially with a rabbit anti-PE Ab (Abcam), horseradish peroxidase-conjugated swine anti-rabbit Ig (Dako) and 3,3′-diaminobenzidine tetrahydrochloride substrate (ThermoFisher). After a final wash, sections were counterstained with hematoxylin, dehydrated via sequential passages in 95%–100% ethanol and xylene, mounted, and analyzed using a Nikon Eclipse Ni microscope with NIS-Elements D software v4.40.  In-situ immunofluorescence staining was performed similarly, but non-specific reactions were blocked with 5% goat serum for 2 h at room temperature before serial incubations with rabbit anti-PE Ab (1:250, 1.5 h at room temperature) and Alexa Fluor 594-conjugated goat anti-rabbit IgG (ThermoFisher; 1:500, 1 h at room temperature). After a further wash, sections were incubated for 1 h at room temperature with rat anti-CD8 mAb (Abcam; 1:100) together with mouse anti-CD45RO mAb (BioLegend; 1:200) followed, after one wash, by one final incubation for 1 h at room temperature with Alexa Fluor 488-conjugated goat anti-rat IgG together with Alexa Fluor 647-conjugated goat anti-mouse IgG (1:500/each; both from ThermoFisher). After DNA counterstaining with DAPI, sections were mounted and analyzed using a Leica TCS SP5 confocal laser scanning microscope with LAS software v2.6.0.7266.			Table S5. Related to Fig. 6. nPOD cases analyzed by in-situ tissue MMr staining.	https://ars.els-cdn.com/content/image/1-s2.0-S1550413118304509-mmc1.pdf
PMID30078552	Gonzalez-Duque et al. (2018)	GonzalezDuque18_pan.MMr.ISL1	pan.MMr.ISL1	counts(x10-3) of Mmr+ cells/mm2 pancreas section area	MMr+ cells reactive for ISL1[276–284] antigen peptide in pancreas	autoreactivity	cell	CD8-positive, alpha-beta T cell	pancreas	0	1	Yes	NA							NA			immunohistochemistry	Culina et al. (2018)				Table S5. Related to Fig. 6. nPOD cases analyzed by in-situ tissue MMr staining.	https://ars.els-cdn.com/content/image/1-s2.0-S1550413118304509-mmc1.pdf
PMID30078552	Gonzalez-Duque et al. (2018)	GonzalezDuque18_pan.MMr.UCN3	pan.MMr.UCN3	counts(x10-3) of Mmr+ cells/mm2 pancreas section area	MMr+ cells reactive for UCN3[1-9] antigen peptide in pancreas	autoreactivity	cell	CD8-positive, alpha-beta T cell	pancreas	0	1	Yes	NA							NA			immunohistochemistry	Culina et al. (2018)				Table S5. Related to Fig. 6. nPOD cases analyzed by in-situ tissue MMr staining.	https://ars.els-cdn.com/content/image/1-s2.0-S1550413118304509-mmc1.pdf
PMID30078552	Gonzalez-Duque et al. (2018)	GonzalezDuque18_pan.MMr.ZnT8	pan.MMr.ZnT8	counts(x10-3) of Mmr+ cells/mm2 pancreas section area	MMr+ cells reactive for ZnT8[186-194] antigen peptide (positive control) in pancreas	autoreactivity	cell	CD8-positive, alpha-beta T cell	pancreas	0	1	Yes	NA							NA			immunohistochemistry	Culina et al. (2018)				Table S5. Related to Fig. 6. nPOD cases analyzed by in-situ tissue MMr staining.	https://ars.els-cdn.com/content/image/1-s2.0-S1550413118304509-mmc1.pdf
PMID30078552	Gonzalez-Duque et al. (2018)	GonzalezDuque18_pan.MMr.MelanA	pan.MMr.MelanA	counts(x10-3) of Mmr+ cells/mm2 pancreas section area	MMr+ cells reactive for MelanA[26-35] antigen peptide (negative control) in pancreas	autoreactivity	cell	CD8-positive, alpha-beta T cell	pancreas	0	1	Yes	NA							NA			immunohistochemistry	Culina et al. (2018)				Table S5. Related to Fig. 6. nPOD cases analyzed by in-situ tissue MMr staining.	https://ars.els-cdn.com/content/image/1-s2.0-S1550413118304509-mmc1.pdf
PMID30078552	Gonzalez-Duque et al. (2018)	GonzalezDuque18_PLN.MMr.IAPP	PLN.MMr.IAPP	counts(x10-3) of Mmr+ cells/mm2 PLN section area	MMr+ cells reactive for IAPP[15-17/5-10] antigen peptide in pancreatic lymph node	autoreactivity	cell	CD8-positive, alpha-beta T cell	pancreatic lymph node	0	1	Yes	NA							NA			immunohistochemistry	Culina et al. (2018)				Table S5. Related to Fig. 6. nPOD cases analyzed by in-situ tissue MMr staining.	https://ars.els-cdn.com/content/image/1-s2.0-S1550413118304509-mmc1.pdf
PMID30078552	Gonzalez-Duque et al. (2018)	GonzalezDuque18_PLN.MMr.ISL1	PLN.MMr.ISL1	counts(x10-3) of Mmr+ cells/mm2 PLN section area	MMr+ cells reactive for ISL1[276–284] antigen peptide in pancreatic lymph node	autoreactivity	cell	CD8-positive, alpha-beta T cell	pancreatic lymph node	0	1	Yes	NA							NA			immunohistochemistry	Culina et al. (2018)				Table S5. Related to Fig. 6. nPOD cases analyzed by in-situ tissue MMr staining.	https://ars.els-cdn.com/content/image/1-s2.0-S1550413118304509-mmc1.pdf
PMID30078552	Gonzalez-Duque et al. (2018)	GonzalezDuque18_PLN.MMr.UCN3	PLN.MMr.UCN3	counts(x10-3) of Mmr+ cells/mm2 PLN section area	MMr+ cells reactive for UCN3[1-9] antigen peptide in pancreatic lymph node	autoreactivity	cell	CD8-positive, alpha-beta T cell	pancreatic lymph node	0	1	Yes	NA							NA			immunohistochemistry	Culina et al. (2018)				Table S5. Related to Fig. 6. nPOD cases analyzed by in-situ tissue MMr staining.	https://ars.els-cdn.com/content/image/1-s2.0-S1550413118304509-mmc1.pdf
PMID30078552	Gonzalez-Duque et al. (2018)	GonzalezDuque18_PLN.MMr.ZnT8	PLN.MMr.ZnT8	counts(x10-3) of Mmr+ cells/mm2 PLN section area	MMr+ cells reactive for ZnT8[186-194] antigen peptide (positive control) in pancreatic lymph node	autoreactivity	cell	CD8-positive, alpha-beta T cell	pancreatic lymph node	0	1	Yes	NA							NA			immunohistochemistry	Culina et al. (2018)				Table S5. Related to Fig. 6. nPOD cases analyzed by in-situ tissue MMr staining.	https://ars.els-cdn.com/content/image/1-s2.0-S1550413118304509-mmc1.pdf
PMID30078552	Gonzalez-Duque et al. (2018)	GonzalezDuque18_PLN.MMr.MelanA	PLN.MMr.MelanA	counts(x10-3) of Mmr+ cells/mm2 PLN section area	MMr+ cells for MelanA[26-35] antigen peptide (negative control) in pancreatic lymph node	autoreactivity	cell	CD8-positive, alpha-beta T cell	pancreatic lymph node	0	1	Yes	NA							NA			immunohistochemistry	Culina et al. (2018)				Table S5. Related to Fig. 6. nPOD cases analyzed by in-situ tissue MMr staining.	https://ars.els-cdn.com/content/image/1-s2.0-S1550413118304509-mmc1.pdf
PMID29771178	Canzano et al. (2018)	Canzano18_InsPos.CD3Neg.prct	InsPos.CD3Neg.prct	%	Percent of islets that are Ins-positive and CD3-negative	insulitis parameters	cell	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Campbell-Thompson et al. (2016)			Percent was calculated from original count data.	ESM Table 1(A). Type 1 diabetes donor islet and exocrine vessel parameters.	http://journals.sagepub.com/doi/suppl/10.1369/0022155418778546/suppl_file/DS_10.1369_0022155418778546.pdf
PMID29771178	Canzano et al. (2018)	Canzano18_InsPos.CD3Pos.prct	InsPos.CD3Pos.prct	%	Percent of islets that are Ins-positive and CD3-positive	insulitis parameters	cell	T cell	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Campbell-Thompson et al. (2016)			Percent was calculated from original count data.	ESM Table 1(A). Type 1 diabetes donor islet and exocrine vessel parameters.	http://journals.sagepub.com/doi/suppl/10.1369/0022155418778546/suppl_file/DS_10.1369_0022155418778546.pdf
PMID29771178	Canzano et al. (2018)	Canzano18_InsNeg.CD3Neg.prct	InsNeg.CD3Neg.prct	%	Percent of islets that are Ins-negative and CD3-negative	insulitis parameters	cell	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Campbell-Thompson et al. (2016)			Percent was calculated from original count data.	ESM Table 1(A). Type 1 diabetes donor islet and exocrine vessel parameters.	http://journals.sagepub.com/doi/suppl/10.1369/0022155418778546/suppl_file/DS_10.1369_0022155418778546.pdf
PMID29771178	Canzano et al. (2018)	Canzano18_vessel.diameter.islet	vessel.diameter.islet	(micrometer)	Vessel diameter in islet	vascular parameters	tissue	blood vessel	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Canzano et al. (2018)				ESM Table 1(A). Type 1 diabetes donor islet and exocrine vessel parameters.	http://journals.sagepub.com/doi/suppl/10.1369/0022155418778546/suppl_file/DS_10.1369_0022155418778546.pdf
PMID29771178	Canzano et al. (2018)	Canzano18_vessel.density.islet	vessel.density.islet	(10^4/micrometer^2)	Vessel density in islet	vascular parameters	tissue	blood vessel	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Canzano et al. (2018)				ESM Table 1(A). Type 1 diabetes donor islet and exocrine vessel parameters.	http://journals.sagepub.com/doi/suppl/10.1369/0022155418778546/suppl_file/DS_10.1369_0022155418778546.pdf
PMID29771178	Canzano et al. (2018)	Canzano18_vessel.area.prct.islet	vessel.area.prct.islet	%	Vessel area as percent of islet	vascular parameters	tissue	blood vessel	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Canzano et al. (2018)				ESM Table 1(A). Type 1 diabetes donor islet and exocrine vessel parameters.	http://journals.sagepub.com/doi/suppl/10.1369/0022155418778546/suppl_file/DS_10.1369_0022155418778546.pdf
PMID29771178	Canzano et al. (2018)	Canzano18_SMA.area.prct.islet	SMA.area.prct.islet	%	Smooth muscle actin area as percent of islet	vascular parameters	tissue	blood vessel	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Canzano et al. (2018)				ESM Table 1(A). Type 1 diabetes donor islet and exocrine vessel parameters.	http://journals.sagepub.com/doi/suppl/10.1369/0022155418778546/suppl_file/DS_10.1369_0022155418778546.pdf
PMID29771178	Canzano et al. (2018)	Canzano18_SMA.area.prct.exocrine	SMA.area.prct.exocrine	%	Smooth muscle actin area as percent of exocrine tissue	vascular parameters	tissue	blood vessel	exocrine pancreas	0	1	Yes	NA							NA			immunostaining	Canzano et al. (2018)				ESM Table 1(B). Type 1 diabetes donor islet and exocrine vessel parameters.	http://journals.sagepub.com/doi/suppl/10.1369/0022155418778546/suppl_file/DS_10.1369_0022155418778546.pdf
PMID29771178	Canzano et al. (2018)	Canzano18_vessel.diameter.exocrine	vessel.diameter.exocrine	(micrometer)	Vessel diameter in exocrine tissue	vascular parameters	tissue	blood vessel	exocrine pancreas	0	1	Yes	NA							NA			immunostaining	Canzano et al. (2018)				ESM Table 1(B). Type 1 diabetes donor islet and exocrine vessel parameters.	http://journals.sagepub.com/doi/suppl/10.1369/0022155418778546/suppl_file/DS_10.1369_0022155418778546.pdf
PMID29771178	Canzano et al. (2018)	Canzano18_vessel.density.exocrine	vessel.density.exocrine	(10^4/micrometer^2)	Vessel density in exocrine tissue	vascular parameters	tissue	blood vessel	exocrine pancreas	0	1	Yes	NA							NA			immunostaining	Canzano et al. (2018)				ESM Table 1(B). Type 1 diabetes donor islet and exocrine vessel parameters.	http://journals.sagepub.com/doi/suppl/10.1369/0022155418778546/suppl_file/DS_10.1369_0022155418778546.pdf
PMID29771178	Canzano et al. (2018)	Canzano18_vessel.area.prct.exocrine	vessel.area.prct.exocrine	%	Vessel area as percent of exocrine tissue	vascular parameters	tissue	blood vessel	exocrine pancreas	0	1	Yes	NA							NA			immunostaining	Canzano et al. (2018)				ESM Table 1(B). Type 1 diabetes donor islet and exocrine vessel parameters.	http://journals.sagepub.com/doi/suppl/10.1369/0022155418778546/suppl_file/DS_10.1369_0022155418778546.pdf
PMID29415062	Simeonovic et al. (2018)	Simeonovic18_HS	HS	mean % islet area stained	Expression of heparan sulfate	HSPG core proteins	protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA	CHEBI:28815	MP:0013258	abnormal extracellular matrix morphology				1	Significantly higher in T1D		immunostaining	Simeonovic et al. (2018)	IHC image to % islet area stained was quantified using ImageJ.		Mean % was manually calculated from multiple stains per case raw data available.	S1 Table: Percentage of islet area stained for HS, HSPGs (Col18 and Sdc1), insulin and glucagon in normal healthy and T1D human pancreases.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802856/bin/pone.0191360.s006.xlsx
PMID29415062	Simeonovic et al. (2018)	Simeonovic18_Col18	Col18	mean % islet area stained	Expression on collagen type XVIII	HSPG core proteins	protein	islet of Langerhans	islet of Langerhans	0	1	Yes	80781		MP:0013258	abnormal extracellular matrix morphology				1	Significantly higher in T1D		immunostaining	Simeonovic et al. (2018)	IHC image to % islet area stained was quantified using ImageJ.		Mean % was manually calculated from multiple stains per case raw data available.	S1 Table: Percentage of islet area stained for HS, HSPGs (Col18 and Sdc1), insulin and glucagon in normal healthy and T1D human pancreases.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802856/bin/pone.0191360.s006.xlsx
PMID29415062	Simeonovic et al. (2018)	Simeonovic18_Sdc1	Sdc1	mean % islet area stained	Expression of syndecan-1	HSPG core proteins	protein	islet of Langerhans	islet of Langerhans	0	1	Yes	6382		MP:0013258	abnormal extracellular matrix morphology				1	Significantly higher in T1D		immunostaining	Simeonovic et al. (2018)	IHC image to % islet area stained was quantified using ImageJ.		Mean % was manually calculated from multiple stains per case raw data available.	S1 Table: Percentage of islet area stained for HS, HSPGs (Col18 and Sdc1), insulin and glucagon in normal healthy and T1D human pancreases.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802856/bin/pone.0191360.s006.xlsx
PMID29415062	Simeonovic et al. (2018)	Simeonovic18_Ins	Ins	mean % islet area stained	Expression of insulin	beta cell parameters	protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0020578	abnormal pancreatic beta cell number				1	Significantly lower in T1D		immunostaining	Simeonovic et al. (2018)	IHC image to % islet area stained was quantified using ImageJ.		Mean % was manually calculated from multiple stains per case raw data available.	S1 Table: Percentage of islet area stained for HS, HSPGs (Col18 and Sdc1), insulin and glucagon in normal healthy and T1D human pancreases.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802856/bin/pone.0191360.s006.xlsx
PMID29415062	Simeonovic et al. (2018)	Simeonovic18_Gcg	Gcg	mean % islet area stained	Expression of glucagon	alpha cell parameters	protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0020577	abnormal pancreatic alpha cell number				1	Significantly higher in T1D		immunostaining	Simeonovic et al. (2018)	IHC image to % islet area stained was quantified using ImageJ.		Mean % was manually calculated from multiple stains per case raw data available.	S1 Table: Percentage of islet area stained for HS, HSPGs (Col18 and Sdc1), insulin and glucagon in normal healthy and T1D human pancreases.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802856/bin/pone.0191360.s006.xlsx
PMID29352311	Bonnet-Serrano et al. (2018)	BonnetSerrano18_alpha.mass	alpha.mass	g	Mass of alpha cells	alpha cell parameters	cell	pancreatic A cell	islet of Langerhans	0	1	Pending authorization	NA		MP:0030587	abnormal pancreatic alpha cell mass				NA			immunostaining	Bonnet-Serrano et al. (2018)					
PMID29352311	Bonnet-Serrano et al. (2018)	BonnetSerrano18_beta.mass	beta.mass	g	Mass of beta cells	beta cell parameters	cell	type B pancreatic cell	islet of Langerhans	0	1	Pending authorization	NA		MP:0009112	abnormal pancreatic beta cell mass				NA			immunostaining	Bonnet-Serrano et al. (2018)					
PMID29326366	Lam et al. (2018)	Lam18_Ki67.Syn.prct	Ki67.Syn.prct	Ki67+Syn+ (% total Syn+)	Synaptophysin cell proliferation; Syn+Ki67+ cells as % of total Syn+ cells	neuroendocrine cell parameters	cell	neuroendocrine cell	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Lam et al. (2018)				Supplemental Table 7. Individual islet endocrine and α-cell proliferation from non-diabetic pancreata. & Supplemental Table 8. Individual islet endocrine and α-cell proliferation from T1D pancreta.	http://diabetes.diabetesjournals.org/highwire/filestream/80633/field_highwire_adjunct_files/0/DB171114SupplementaryData.pdf
PMID29326366	Lam et al. (2018)	Lam18_Ki67.Gcg.prct	Ki67.Gcg.prct	Ki67+alpha cells (% total alpha cells)	Alpha cell proliferation; Ki67+alpha cells as % of total alpha cells	alpha cell parameters	cell	pancreatic A cell	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Lam et al. (2018)				Supplemental Table 7. Individual islet endocrine and α-cell proliferation from non-diabetic pancreata. & Supplemental Table 8. Individual islet endocrine and α-cell proliferation from T1D pancreta.	http://diabetes.diabetesjournals.org/highwire/filestream/80633/field_highwire_adjunct_files/0/DB171114SupplementaryData.pdf
PMID29326366	Lam et al. (2018)	Lam18_Ki67.Syn.intraislet.prct	Ki67.Syn.intraislet.prct	Ki67+Syn+ (% total Ki67+)	Synaptophysin cell proliferation; Syn+Ki67+ cells in as percent of total intraislet Ki67+ cells	neuroendocrine cell parameters	cell	neuroendocrine cell	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Lam et al. (2018)				Supplemental Table 9. Individual synaptophysin cell proliferation expressed as % of intraislet Ki67+ cells in non-diabetic and T1D pancreata.	http://diabetes.diabetesjournals.org/highwire/filestream/80633/field_highwire_adjunct_files/0/DB171114SupplementaryData.pdf
PMID29326366	Lam et al. (2018)	Lam18_alpha.cells	alpha.cells	Alpha cells (per islet)	Alpha cell abundance; number of alpha cells per islet	alpha cell parameters	cell	pancreatic A cell	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Lam et al. (2018)				Supplemental Table 11. Average α-cell number per islet cross section of non-diabetic and T1D samples.	http://diabetes.diabetesjournals.org/highwire/filestream/80633/field_highwire_adjunct_files/0/DB171114SupplementaryData.pdf
PMID29326366	Lam et al. (2018)	Lam18_Ki67.alpha.cells	Ki67.alpha.cells	Ki67+alpha-cells (per islet)	Alpha cell proliferation; number of Ki67+ alpha cells per islet	alpha cell parameters	cell	pancreatic A cell	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Lam et al. (2018)				Supplemental Table 11. Average α-cell number per islet cross section of non-diabetic and T1D samples.	http://diabetes.diabetesjournals.org/highwire/filestream/80633/field_highwire_adjunct_files/0/DB171114SupplementaryData.pdf
PMID29326366	Lam et al. (2018)	Lam18_Ki67.alpha.cells.prct	Ki67.alpha.cells.prct	Ki67+ alpha-cells (% total Ki67+)	Alpha cell proliferation; Ki67+ alpha cell as percent of total intraislet Ki67+ cells	alpha cell parameters	cell	pancreatic A cell	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Lam et al. (2018)				Supplemental Table 12. Individual α-cell proliferation expressed as % of intraislet Ki67+ cells in non-diabetic and T1D pancreata.	http://diabetes.diabetesjournals.org/highwire/filestream/80633/field_highwire_adjunct_files/0/DB171114SupplementaryData.pdf
PMID29326366	Lam et al. (2018)	Lam18_Ki67.PP.prct	Ki67.PP.prct	Ki67+PP+ cells (% total PP+)	PP cell proliferation; Ki67+ PP cells as percent of total PP+ cells		cell	progenitor cell of endocrine pancreas	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Lam et al. (2018)				Supplemental Table 13. Individual PP, somatostatin, and ghrelin cell proliferation from non-diabetic and T1D pancreta.	http://diabetes.diabetesjournals.org/highwire/filestream/80633/field_highwire_adjunct_files/0/DB171114SupplementaryData.pdf
PMID29326366	Lam et al. (2018)	Lam18_Ki67.Sst.prct	Ki67.Sst.prct	Ki67+Somatostatin+ cells (% total Sst+)	Somatostatin cell proliferation; Ki67+ Sst+ cells as percent of total Sst+ cells	somatostatin cell parameters	cell	pancreatic D cell	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Lam et al. (2018)				Supplemental Table 13. Individual PP, somatostatin, and ghrelin cell proliferation from non-diabetic and T1D pancreta.	http://diabetes.diabetesjournals.org/highwire/filestream/80633/field_highwire_adjunct_files/0/DB171114SupplementaryData.pdf
PMID29326366	Lam et al. (2018)	Lam18_Ki67.Grh.prct	Ki67.Grh.prct	Ki67+Ghrelin+ cells (% total Grh+)	Ghrelin cell proliferation; Ki67+ Grh+ cells as percent of total Grh+ cells		cell	pancreatic epsilon cell	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Lam et al. (2018)				Supplemental Table 13. Individual PP, somatostatin, and ghrelin cell proliferation from non-diabetic and T1D pancreta.	http://diabetes.diabetesjournals.org/highwire/filestream/80633/field_highwire_adjunct_files/0/DB171114SupplementaryData.pdf
PMID29326366	Lam et al. (2018)	Lam18_Ki67.Sox9.prct.1	Ki67.Sox9.prct.1	Ki67+Sox9Cyt+ cells (% total Sox9Cyt+)	Sox9 cell proliferation; Ki67+Sox9Cyt+ cells as % of total Sox9Cyt+ cells		cell	islet of Langerhans	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Lam et al. (2018)				Supplemental Table 16. Individual cytoplasmic Sox9 cell proliferation from non-diabetic and T1D samples.	http://diabetes.diabetesjournals.org/highwire/filestream/80633/field_highwire_adjunct_files/0/DB171114SupplementaryData.pdf
PMID29326366	Lam et al. (2018)	Lam18_Ki67.Sox9.prct.2	Ki67.Sox9.prct.2	Ki67+ Sox9Cyt+ cells (% total intraislet Ki67+)	Sox9 cell proliferation; Ki67+Sox9Cyt+ cells as % of total intraislet Ki67+ cells		cell	islet of Langerhans	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Lam et al. (2018)				Supplemental Table 16. Individual cytoplasmic Sox9 cell proliferation from non-diabetic and T1D samples.	http://diabetes.diabetesjournals.org/highwire/filestream/80633/field_highwire_adjunct_files/0/DB171114SupplementaryData.pdf
PMID29326366	Lam et al. (2018)	Lam18_islet.mass	islet.mass	Islet endocrine mass (g)	Islet endocrine mass	islet parameters	cell	islet of Langerhans	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Lam et al. (2018)				Supplemental Table 23. Control and T1D Islet Cell Area & Mass.	http://diabetes.diabetesjournals.org/highwire/filestream/80633/field_highwire_adjunct_files/0/DB171114SupplementaryData.pdf
PMID29222447	Bogdani et al. (2017)	Bogdani17_Ki67.Ins.cells	Ki67.Ins.cells	% Ki67+/Ins+ cells	Beta-cell proliferation	beta cell parameters	cell	type B pancreatic cell	islet of Langerhans	0	1	Contact authors	NA		MP:0011818	abnormal pancreatic beta cell proliferation				NA			immunostaining	Bogdani et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722914/figure/Fig3/
PMID29222447	Bogdani et al. (2017)	Bogdani17_CK19.Ins.cells	CK19.Ins.cells	% CK19+/Ins+ cells	Beta-cell neogenesis	beta cell parameters	cell	type B pancreatic cell	islet of Langerhans	0	1	Contact authors	NA		MP:0011818	abnormal pancreatic beta cell proliferation				NA			immunostaining	Bogdani et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722914/figure/Fig3/
PMID29222447	Bogdani et al. (2017)	Bogdani17_CF.grade	CF.grade	grade	Cystic fibrosis histopathologic grade based on staining	other autoimmune disease	cell			0	1	Contact authors	NA							NA			immunostaining	Klöppel and Maillet (1991)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722914/figure/Fig2/
PMID29222447	Bogdani et al. (2017)	Bogdani17_Ins	Ins	% Ins+ cells	Percent of insulin-positive cells in islet	islet parameters	cell	type B pancreatic cell	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Bogdani et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722914/figure/Fig2/
PMID29222447	Bogdani et al. (2017)	Bogdani17_Synaptophysin	Synaptophysin	% Syn+ area stained	Relative pancreas synaptophysin area stained	neuroendocrine cell parameters	protein	neuroendocrine cell	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Bogdani et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722914/figure/Fig2/
PMID29222447	Bogdani et al. (2017)	Bogdani17_CFTR.mut	CFTR.mut	Positive/Negative	Genotyping for 159 CFTR variants	other autoimmune disease	genotype			1	159	Contact authors	NA				EFO:0000513	genotype		NA			MALDI-TOF	Bogdani et al. (2014)					
PMID29128936	Kusmartseva et al. (2017)	Kusmartseva17_hosp.bin	hosp.bin	(level)	hospitalisation time, binned	clinical	clinical			0	1	Yes	NA							NA			immunostaining	Kusmartseva et al. (2017)					https://doi.org/10.5281/zenodo.1034422
PMID29128936	Kusmartseva et al. (2017)	Kusmartseva17_Ki67.cells.prct	Ki67.cells.prct	%	Mean Ki67+ cells as percentage of total islet cells counted	proliferation	cell	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0005518	abnormal pancreas regeneration				NA			immunostaining	Kusmartseva et al. (2017)					https://doi.org/10.5281/zenodo.1034422
PMID29128936	Kusmartseva et al. (2017)	Kusmartseva17_Ki67.Ins.cells.prct	Ki67.Ins.cells.prct	%	Mean Ki67+/Ins+ cells as percentage of total islet cells counted	beta cell parameters	cell	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0011818	abnormal pancreatic beta cell proliferation				NA			immunostaining	Kusmartseva et al. (2017)					https://doi.org/10.5281/zenodo.1034422
PMID29128936	Kusmartseva et al. (2017)	Kusmartseva17_CD45.cells.prct	CD45.cells.prct	%	Mean CD45+ cells as percentage of total islet cells counted	insulitis parameters	cell	leukocyte	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Kusmartseva et al. (2017)					https://doi.org/10.5281/zenodo.1034422
PMID29128936	Kusmartseva et al. (2017)	Kusmartseva17_CD68.cells.prct	CD68.cells.prct	%	Mean CD68+ cells as percentage of total islet cells counted	leukocyte infiltration	cell	macrophage	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Kusmartseva et al. (2017)					https://doi.org/10.5281/zenodo.1034422
PMID28878130	Levet et al. (2017)	Levet17_Env03	Env03	% positive staining area	HERV-W-Env protein expression in pancreas as percent positive area of total pancreatic tissue area	viral-related	protein	pancreas	pancreas	0	1	Pending authorization	NA						1	1			immunostaining	Levet et al. (2017)	HERV-W-Env expression was assessed on pancreas slices from controls (n = 19) and T1D (n = 20) stained using GN_mAb_Env03 and automatically quantified.				https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621895/figure/F1/
PMID28878130	Levet et al. (2017)	Levet17_CD3.cells.islet.prct	CD3.cells.islet.prct	%	CD3+ cells as percent of total cells counted in islet	insulitis parameters	cell	T cell	islet of Langerhans	0	1	Pending authorization	NA							NA			immunostaining	Levet et al. (2017)					
PMID28878130	Levet et al. (2017)	Levet17_CD3.cells.islet	CD3.cells.islet	count	Mean CD3+ cells in islet per mm^2	insulitis parameters	cell	T cell	islet of Langerhans	0	1	Pending authorization	NA							NA			immunostaining	Levet et al. (2017)					
PMID28878130	Levet et al. (2017)	Levet17_CD68.cells.islet.prct	CD68.cells.islet.prct	%	CD68+ cells as percent of total cells counted in islet	leukocyte infiltration	cell	macrophage	islet of Langerhans	0	1	Pending authorization	NA							NA			immunostaining	Levet et al. (2017)					
PMID28878130	Levet et al. (2017)	Levet17_CD68.cells.islet	CD68.cells.islet	count	Mean CD68+ cells in islet per mm^2	leukocyte infiltration	cell	macrophage	islet of Langerhans	0	1	Pending authorization	NA							NA			immunostaining	Levet et al. (2017)					
PMID28878130	Levet et al. (2017)	Levet17_CD3.cells.exocrine.prct	CD3.cells.exocrine.prct	%	CD3+ cells as percent of total cells counted in exocrine pancreas	insulitis parameters	cell	T cell	exocrine pancreas	0	1	Pending authorization	NA							NA			immunostaining	Levet et al. (2017)					
PMID28878130	Levet et al. (2017)	Levet17_CD3.cells.exocrine	CD3.cells.exocrine	count	Mean CD3+ cells in exocrine pancreas per mm^2	insulitis parameters	cell	T cell	exocrine pancreas	0	1	Pending authorization	NA							NA			immunostaining	Levet et al. (2017)					
PMID28878130	Levet et al. (2017)	Levet17_CD68.cells.exocrine.prct	CD68.cells.exocrine.prct	%	CD68+ cells as percent of total cells counted in exocrine pancreas	leukocyte infiltration	cell	macrophage	exocrine pancreas	0	1	Pending authorization	NA							NA			immunostaining	Levet et al. (2017)					
PMID28878130	Levet et al. (2017)	Levet17_CD68.cells.exocrine	CD68.cells.exocrine	count	Mean CD68+ cells in exocrine pancreas per mm^2	leukocyte infiltration	cell	macrophage	exocrine pancreas	0	1	Pending authorization	NA							NA			immunostaining	Levet et al. (2017)					
PMID28877460	Wasserfall et al. (2017)	Wasserfall17_Ins.pos.prct	Ins.pos.prct	%	% Ins+ average, Aperio calc area	beta cell parameters	protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA							NA			ELISA	Wasserfall et al. (2017)					
PMID28877460	Wasserfall et al. (2017)	Wasserfall17_Ins	Ins	uIU/ug	Ins protein concentration	beta cell parameters	protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA						1	1			ELISA	Wasserfall et al. (2017)	Acid-ethanol extraction of protein from randomly localized pancreatic blocks, determined and normalized against total protein.				https://ars.els-cdn.com/content/image/1-s2.0-S1550413117304989-mmc2.xlsx
PMID28877460	Wasserfall et al. (2017)	Wasserfall17_Cpeptide	Cpeptide	pM/ug	Cpeptide protein concentration	beta cell parameters	protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA						1	1			ELISA	Wasserfall et al. (2017)	Acid-ethanol extraction of protein from randomly localized pancreatic blocks, determined and normalized against total protein.				https://ars.els-cdn.com/content/image/1-s2.0-S1550413117304989-mmc2.xlsx
PMID28877460	Wasserfall et al. (2017)	Wasserfall17_ProIns	ProIns	pM/ug	Proinsulin ELISA normalized against total protein	beta cell parameters	protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA						1	1			ELISA	Wasserfall et al. (2017)	Acid-ethanol extraction of protein from randomly localized pancreatic blocks, determined and normalized against total protein.				https://ars.els-cdn.com/content/image/1-s2.0-S1550413117304989-mmc2.xlsx
PMID28877460	Wasserfall et al. (2017)	Wasserfall17_Amylin	Amylin	pg/ug	Islet amyloid polypeptide ELISA normalized against total protein	amyloid	protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA						0	0			ELISA	Wasserfall et al. (2017)	Acid-ethanol extraction of protein from randomly localized pancreatic blocks, determined and normalized against total protein.				https://ars.els-cdn.com/content/image/1-s2.0-S1550413117304989-mmc2.xlsx
PMID28877460	Wasserfall et al. (2017)	Wasserfall17_Glucagon	Glucagon	pmol/L/ug	Glucagon ELISA normalized against total protein	alpha cell parameters	protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA						1	1			immunostaining	Wasserfall et al. (2017)					https://ars.els-cdn.com/content/image/1-s2.0-S1550413117304989-mmc2.xlsx
PMID28877460	Wasserfall et al. (2017)	Wasserfall17_GCGpos.INSneg	GCGpos.INSneg	count	Count of glucagon-positive, insulin-negative cells	alpha cell parameters	cell	pancreatic A cell	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Wasserfall et al. (2017)					
PMID28877460	Wasserfall et al. (2017)	Wasserfall17_GCGpos.INSpos	GCGpos.INSpos	count	Count of glucagon-positive, insulin-positive cells		cell	type B pancreatic cell|pancreatic A cell	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Wasserfall et al. (2017)					
PMID28877460	Wasserfall et al. (2017)	Wasserfall17_INSpos.single	INSpos.single	count	Count of insulin-positive single cells	beta cell parameters	cell	type B pancreatic cell	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Wasserfall et al. (2017)					
PMID28877460	Wasserfall et al. (2017)	Wasserfall17_INSpos.cluster	INSpos.cluster	count	Count of insulin-positive clusters containing 2-5 cells	beta cell parameters	cell	type B pancreatic cell	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Wasserfall et al. (2017)					
PMID28877242	Nyalwidhe et al. (2017)	Nyalwidhe17_Proteomics	Proteomics	LFQ intensity	Proteomics of islet tissue, expression data for ~1500 proteins 	islet parameters	protein	islet of Langerhans	islet of Langerhans	1	1500	Yes	NA							1			liquid chromatography-tandem mass spectrometry	Nyalwidhe et al. (2017)	High resolution high mass accuracy label free quantitative mass spectrometry analysis was applied to islets isolated by laser capture microdissection.			S4 Table: Qualitative and quantitative comparisons between non-diabetes versus autoantibody cases and T1D cases.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587329/bin/pone.0183908.s006.xlsx
PMID28782056	Moin et al. (2017)	Moin17_CgA.cells	CgA.cells	%	Presence and frequency of CPHN cells identified by anti-chromogranin A staining (%CPHN of endocrine cells)		protein	pancreatic endocrine cell	islet of Langerhans	0	1	Contact authors	NA						1* freq differs in adult but not children	0			immunostaining	Moin et al. (2017)					
PMID28782056	Moin et al. (2017)	Moin17_Ki67.CgA.cells	Ki67.CgA.cells	%	Frequency of replicating CPHN cells identified with Ki67+ staining		protein	pancreatic endocrine cell	islet of Langerhans	0	1	Contact authors	NA						1* freq differs in adult but not children	0			immunostaining	Moin et al. (2017)					
PMID28782056	Moin et al. (2017)	Moin17_Nkx61.CgA.cells	Nkx61.CgA.cells	%	Frequency of replicating CPHN cells identified with endocrine markers by Nkx6.1+ staining and reported as % of CPHN cells		protein	pancreatic endocrine cell	islet of Langerhans	0	1	Contact authors	NA						1* freq differs in adult but not children	0			immunostaining	Moin et al. (2017)					
PMID28782056	Moin et al. (2017)	Moin17_Nkx22.CgA.cells	Nkx22.CgA.cells	%	Frequency of replicating CPHN cells identified with endocrine markers by Nkx2.2+ staining and reported as % of CPHN cells		protein	pancreatic endocrine cell	islet of Langerhans	0	1	Contact authors	NA						1* freq differs in adult but not children	0			immunostaining	Moin et al. (2017)					
PMID28761107	Sebastiani et al. (2017)	Sebastiani17_miRs.Treg.PLN	miRs.Treg.PLN	dCT	microRNA expression of Tregs from pancreatic lymph node (384 miRs measured)	miRNA	RNA	regulatory T cell	pancreatic lymph node	1	384	Contact authors	NA							1			real time polymerase chain reaction assay	Sebastiani et al. (2017)	Cycles to Threshold (Ct) of PCR and Ct are normalized (dCt) using small RNAs endogenous controls (RNU6A, RNU48, RNU44).				https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537269/figure/Fig1/
PMID28761107	Sebastiani et al. (2017)	Sebastiani17_miRs.Treg.PB	miRs.Treg.PB	dCT	microRNA expression of Tregs from peripheral blood (384 miRs measured)	miRNA	RNA	regulatory T cell	blood	1	384	Contact authors	NA							1			real time polymerase chain reaction assay	Sebastiani et al. (2017)	Cycles to Threshold (Ct) of PCR and Ct are normalized (dCt) using small RNAs endogenous controls (RNU6A, RNU48, RNU44)				https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537269/figure/Fig1/
PMID28761107	Sebastiani et al. (2017)	Sebastiani17_miR125.Treg.PB	miR125.Treg.PB	2^-dCT	miR-125a-5p relative expression measured by real time-PCR in Treg cells purified from peripheral blood	miRNA	RNA	regulatory T cell	blood	0	1	Contact authors	NA							1			real time polymerase chain reaction assay	Sebastiani et al. (2017)	2^-delta cycle threshold (2-dCT) values normalized using three different small RNAs (RNU6, RNU44, RNU48).				https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537269/figure/Fig2/
PMID28761107	Sebastiani et al. (2017)	Sebastiani17_miR125.Treg.PLN	miR125.Treg.PLN	2^-dCT	miR-125a-5p relative expression measured by real time-PCR in Treg cells purified from pancreatic lymph node	miRNA	RNA	regulatory T cell	pancreatic lymph node	0	1	Contact authors	NA							1			real time polymerase chain reaction assay	Sebastiani et al. (2017)	2^-delta cycle threshold (2-dCT) values normalized using three different small RNAs (RNU6, RNU44, RNU48).				https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537269/figure/Fig2/
PMID28761107	Sebastiani et al. (2017)	Sebastiani17_miR125.Tconv.PB	miR125.Tconv.PB	2^-dCT	miR-125a-5p relative expression measured by real time-PCR in Tconv cells purified from peripheral blood	miRNA	RNA	helper T cell	blood	0	1	Contact authors	NA							1			real time polymerase chain reaction assay	Sebastiani et al. (2017)	2^-delta cycle threshold (2-dCT) values normalized using three different small RNAs (RNU6, RNU44, RNU48).				https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537269/figure/Fig2/
PMID28761107	Sebastiani et al. (2017)	Sebastiani17_miR125.Tconv.PLN	miR125.Tconv.PLN	2^-dCT	miR-125a-5p relative expression measured by real time-PCR in Tconv cells purified from pancreatic lymph node	miRNA	RNA	helper T cell	pancreatic lymph node	0	1	Contact authors	NA							1			real time polymerase chain reaction assay	Sebastiani et al. (2017)	2^-delta cycle threshold (2-dCT) values normalized using three different small RNAs (RNU6, RNU44, RNU48).				https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537269/figure/Fig2/
PMID28761107	Sebastiani et al. (2017)	Sebastiani17_CCL2.Ins	CCL2.Ins	% colocalization rate	Colocalization analysis between CCL2/Insulin by staining	cytokine	protein	type B pancreatic cell	islet of Langerhans	0	1	Contact authors	NA				EFO:0004749	CCL2 measurement		NA			immunostaining	Sebastiani et al. (2017)		CCL2 is primarily expressed by insulin-producing cells in pancreatic islets and and might serve as potential attractant of CCR2-expressing cells.			
PMID28761107	Sebastiani et al. (2017)	Sebastiani17_CCL2.Gcg	CCL2.Gcg	% colocalization rate	Colocalization analysis between CCL2/Glucagon by staining	cytokine	protein	pancreatic A cell	islet of Langerhans	0	1	Contact authors	NA				EFO:0004749	CCL2 measurement		NA			immunostaining	Sebastiani et al. (2017)					
PMID28742858	Thivolet et al. (2017)	Thivolet17_Ip3r2	Ip3r2	pixels/islet	Expression of IP3R2 (as mean fluorescence intensity) in beta cells	mitochondria	protein	type B pancreatic cell	islet of Langerhans	0	1	Yes	3709							1			immunofluorescence	Thivolet et al. (2017)				Table 2: Mean intensity levels in beta cells of IP3R2, TOM20, MFN-2 and VDAC-1 by indirect immunofluorescence and levels of ER-mitochondrial IP3R2-VDAC1 interactions quantified by in situ proximity ligation assay (PA).	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526536/table/pone.0182027.t002/
PMID28742858	Thivolet et al. (2017)	Thivolet17_Tom20	Tom20	pixels/islet	Expression of TOM20 (as mean fluorescence intensity) in beta cells	mitochondria	protein	type B pancreatic cell	islet of Langerhans	0	1	Yes	9804							1			immunofluorescence	Thivolet et al. (2017)				Table 2: Mean intensity levels in beta cells of IP3R2, TOM20, MFN-2 and VDAC-1 by indirect immunofluorescence and levels of ER-mitochondrial IP3R2-VDAC1 interactions quantified by in situ proximity ligation assay (PA).	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526536/table/pone.0182027.t002/
PMID28742858	Thivolet et al. (2017)	Thivolet17_Mfn2	Mfn2	pixels/islet	Expression of MFN-2 (as mean fluorescence intensity) in beta cells	mitochondria	protein	type B pancreatic cell	islet of Langerhans	0	1	Yes	9927							1			immunofluorescence	Thivolet et al. (2017)				Table 2: Mean intensity levels in beta cells of IP3R2, TOM20, MFN-2 and VDAC-1 by indirect immunofluorescence and levels of ER-mitochondrial IP3R2-VDAC1 interactions quantified by in situ proximity ligation assay (PA).	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526536/table/pone.0182027.t002/
PMID28742858	Thivolet et al. (2017)	Thivolet17_Vdac1	Vdac1	pixels/islet	Expression of VDAC-1 (as mean fluorescence intensity) in beta cells	mitochondria	protein	type B pancreatic cell	islet of Langerhans	0	1	Yes	7416							1			immunofluorescence	Thivolet et al. (2017)				Table 2: Mean intensity levels in beta cells of IP3R2, TOM20, MFN-2 and VDAC-1 by indirect immunofluorescence and levels of ER-mitochondrial IP3R2-VDAC1 interactions quantified by in situ proximity ligation assay (PA).	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526536/table/pone.0182027.t002/
PMID28742858	Thivolet et al. (2017)	Thivolet17_Ip3r2.Vdac1	Ip3r2.Vdac1	dots/nucleus	Levels of ER-mitochondrial IP3R2-VDAC1 interactions (quantified by in situ proximity ligation) in beta cells	mitochondria	protein	type B pancreatic cell	islet of Langerhans	0	1	Yes	NA							1			in situ proximity ligation assay (PLA)	Thivolet et al. (2017)	Duolink II in situ proximity ligation assay (PLA) (Olink Bioscience, Uppsala Sweden) enables  detection, visualization, and quantification of protein interactions (<40 nm) as an individual dot by microscopy. Dots were quantified in each islet using the Zen program and Fiji-ImageJ software and expressed as percentage of dots per nucleus. Each dot corresponds to one VDAC-1-IP3R2 interaction closer than 40nm.			Table 2: Mean intensity levels in beta cells of IP3R2, TOM20, MFN-2 and VDAC-1 by indirect immunofluorescence and levels of ER-mitochondrial IP3R2-VDAC1 interactions quantified by in situ proximity ligation assay (PA).	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526536/table/pone.0182027.t002/
PMID28679961	Schludi et al. (2017)	Schludi17_panIN	panIN	PanIN lesions/(mm^2 tissue*10^3)	Pancreatic Intraepithelial Neoplasia lesions scored for density by group-blinded visual evaluation of stained sections		cell	pancreas	pancreas	0	1	Contact authors	NA							1	PanIN is increased and correlated with higher pancreatic duct gland proliferation in T2D vs controls		immunostaining	Schludi et al. (2017)	To identify and score the PanIN lesion density, 6 pancreatic sections were evaluated per case by an experienced pancreatic pathologist (DD) blinded to the group. Two sections were evaluated from the head, body, and tail of the pancreas from each case, one of which was stained with Alcian blue and for insulin and Ki67, and the other by H&E.				
PMID28679961	Schludi et al. (2017)	Schludi17_density.PDG	density.PDG	PDG cells/mm^2	Pancreatic duct gland density characterized by group-blinded visual evaluation of stained sections		cell	pancreas exocrine glandular cell	pancreas	0	1	Contact authors	NA							0	PDGs in human pancreas are present in the head, body, and tail with a comparable abundance in individuals with T2DM and ND controls		immunostaining	Schludi et al. (2017)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499368/figure/F2/
PMID28679961	Schludi et al. (2017)	Schludi17_replication.PDG	replication.PDG	Ki67+ PDG cells/mm^2	Pancreatic duct gland replication characterized by staining for Ki67+ PDGs		cell	pancreas exocrine glandular cell	pancreas	0	1	Contact authors	NA							1	PDG replication was increased 2-fold in T2D vs controls and associated with increased pancreatic intraepithelial neoplasia		immunostaining	Schludi et al. (2017)					
PMID28679961	Schludi et al. (2017)	Schludi17_replication.interduct	replication.interduct	Ki67+ interlobular duct cells/mm^2	Interlobular duct cell replication characterized by staining for Ki67+ duct cells		cell	pancreatic ductal cell	pancreas	0	1	Contact authors	NA							1	Frequency of interlobular duct cells is increased in T2DM vs controls		immunostaining	Schludi et al. (2017)					
PMID28679961	Schludi et al. (2017)	Schludi17_replication.intraduct	replication.intraduct	Ki67+ intralobular duct cells/mm^2	Intralobular duct cell replication characterized by staining for Ki67+ duct cells		cell	pancreatic ductal cell	pancreas	0	1	Contact authors	NA							0	No difference between T2D vs controls in replication of intralobular duct cells		immunostaining	Schludi et al. (2017)					
PMID28614797	Rodnoi et al. (2017)	Rodnoi17_Npy	Npy		NPY expression in beta cells/pancreatic tissue characterized by staining	beta cell dedifferentiation	protein	type B pancreatic cell	pancreas	0	1	Contact authors	NA							1	NPY expression likely promotes replication and contributes to impaired glucose responsiveness in neonatal beta cells; NPY is reexpressed in a subset of beta cells in both T1D and T2D and correlated with greater residual beta cells		immunostaining	Rodnoi et al. (2017)				Supplemental Figure 7	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470892/bin/jciinsight-2-94005-s001.pdf
PMID28581443	Waqas et al. (2017)	Waqas17_NPFF	NPFF	Relative expression	NPFF gene expression profiling in islet tissue		transcript	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							1	Relative transcription of NPFF was reduced in pancreatic islets of T1DM patients		Affymetrix expression array	Waqas et al. (2017)		All islets in 2–5 sections of tissue from each nPOD donor were laser-captured, pooled and RNA extracted. Samples with sufficient quantity and quality of RNA were then subjected to gene expression analysis using Affymetrix expression arrays.		Supplemental Figure 6(H): Distribution of NPFF in mouse and human pancreatic islets	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490745/bin/jci-127-90152-s001.pdf
PMID28428323	Jackson et al. (2017)	Jackson17_CD3.cells	CD3.cells	count	Insulitis measured as mean CD3+ cells per infiltrated islet		cell	T cell	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Campbell-Thompson et al. (2016)					
PMID28428323	Jackson et al. (2017)	Jackson17_beta.mass	beta.mass	g	Beta cell mass		cell	type B pancreatic cell	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Campbell-Thompson et al. (2016)					
PMID28380380	van der Meulen et al. (2017)	vanderMeulen17_Ucn3	Ucn3		Expression of Urocortin3 (UCN3) in beta cells (stained images only)	beta cell transdifferentation	protein	type B pancreatic cell	islet of Langerhans	0	1	Contact authors	114131							NA	Ucn3-negative beta cells are virgin beta cells that represent an intermediate stage in the transdifferentiation of alpha cells into mature beta cells		immunostaining	van der Meulen et al. (2017)				Figure 5. UCN3-Negative Beta Cells Are Present in Human Islets of Young and Adult Donors and Donors with T1D	https://www.sciencedirect.com/science/article/pii/S1550413117301699?via%3Dihub#fig5
PMID28380379	Aguayo-Mazzucato et al. (2017)	AguayoMazzucato17_Igfr1	Igfr1		IGFR1 expression (staining intensity, scale 0-3) as a marker of aging in beta cell	aging	protein	type B pancreatic cell	islet of Langerhans	0	1	Contact authors	NA						1	1			immunostaining	Aguayo-Mazzucato et al. (2017)					https://ars.els-cdn.com/content/image/1-s2.0-S1550413117301675-mmc1.pdf
PMID28380379	Aguayo-Mazzucato et al. (2017)	AguayoMazzucato17_P53bp1	P53bp1		P53BP1 expression (staining intensity)  as a marker of aging in beta cell	aging	protein	type B pancreatic cell	islet of Langerhans	0	1	Contact authors	7158						1	0			immunostaining	Aguayo-Mazzucato et al. (2017)					https://ars.els-cdn.com/content/image/1-s2.0-S1550413117301675-mmc1.pdf
PMID28325643	Anquetil et al. (2017)	Anquetil17_IL1b	IL1b	%	IL1beta mRNA expression measured by in situ hyridization and reported as percentage of the positive area within the islet boundary		transcript	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA				EFO:0004812	interleukin-1 beta measurement	0	0	IL-1beta mRNA expression is independent of BMI and disease status		in-situ hybridization assay	Anquetil et al. (2017)	mRNA expression was quantified with RNAscope 2.0 High Definition BROWN Assay.				
PMID28325643	Anquetil et al. (2017)	Anquetil17_Il1b	Il1b	MIP-MIN	Il1b protein expresson reported as difference of the mean intensity in the positive area (MIP) and the mean intensity in the negative area (MIN, background)		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA				EFO:0004812	interleukin-1 beta measurement	0	0	IL-1beta mRNA expression is independent of BMI and disease status		immunostaining	Anquetil et al. (2017)					
PMID28323930	Lam et al. (2017)	Lam17_Ins.cells	Ins.cells	count	Count of total Insulin+ beta cells	beta cell persistence	cell	type B pancreatic cell	islet of Langerhans	0	1	Yes	NA		MP:0009255	degranulated pancreatic beta cells			1	1			immunostaining	Lam et al. (2017)				Supplemental Table 10: Beta-cell death.	https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jcem/102/8/10.1210_jc.2016-3806/1/jc.2016-3806_Supplemental_Table_1-14.xlsx?Expires=1521155148&Signature=Gl0xp87IMGbQE1zah6aRz-lHuJU6ffk0HGoiq-oF6VVKtfJMtBt9MkR9IKlsXA52~vD7IHsYpcLfBqQlABbYBTEF3suFfag97PErpOI4RGmtWWyEmBHAL2Js~KJ9hkRlQrp5ixDZwcR0olmiw6r1KSi8HEC0kevDRHLUwvaoX6dscyNQLeQiIEMp9WrQ4ZFbuI1COfilS5lrmjJUMIPNSJb5bAXRRP8DK1ZWpcuIY-D7AsBCjk56Tgthn51YggrJrMrLvv0smQndo7rmdiIIFoal8NddkpmAI~S31r5bktI2NYjXES71~gcyFol1fFVb-QkzI30UT6GOhWLCON~Hdw__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q
PMID28323930	Lam et al. (2017)	Lam17_TUNEL.Ins.cells	TUNEL.Ins.cells	%	Quantification of beta cell turnover by measurement of TUNEL+ Ins+ beta-cells and reported as % total cells	beta cell neogenesis	cell	type B pancreatic cell	islet of Langerhans	0	1	Yes	NA						0	0			immunostaining	Lam et al. (2017)				Supplemental Table 10: Beta-cell death.	https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jcem/102/8/10.1210_jc.2016-3806/1/jc.2016-3806_Supplemental_Table_1-14.xlsx?Expires=1521155148&Signature=Gl0xp87IMGbQE1zah6aRz-lHuJU6ffk0HGoiq-oF6VVKtfJMtBt9MkR9IKlsXA52~vD7IHsYpcLfBqQlABbYBTEF3suFfag97PErpOI4RGmtWWyEmBHAL2Js~KJ9hkRlQrp5ixDZwcR0olmiw6r1KSi8HEC0kevDRHLUwvaoX6dscyNQLeQiIEMp9WrQ4ZFbuI1COfilS5lrmjJUMIPNSJb5bAXRRP8DK1ZWpcuIY-D7AsBCjk56Tgthn51YggrJrMrLvv0smQndo7rmdiIIFoal8NddkpmAI~S31r5bktI2NYjXES71~gcyFol1fFVb-QkzI30UT6GOhWLCON~Hdw__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q
PMID28323930	Lam et al. (2017)	Lam17_Ins.cells	Ins.cells	count	Count of beta cells		cell	type B pancreatic cell	islet of Langerhans	0	1	Yes	NA		MP:0020578	abnormal pancreatic beta cell number			1	1			immunostaining	Lam et al. (2017)				Supplemental Table 4: Non-diabetic beta-cell area and mass. & Supplemental Table 5: T1D beta-cell area and mass.	https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jcem/102/8/10.1210_jc.2016-3806/1/jc.2016-3806_Supplemental_Table_1-14.xlsx?Expires=1521155148&Signature=Gl0xp87IMGbQE1zah6aRz-lHuJU6ffk0HGoiq-oF6VVKtfJMtBt9MkR9IKlsXA52~vD7IHsYpcLfBqQlABbYBTEF3suFfag97PErpOI4RGmtWWyEmBHAL2Js~KJ9hkRlQrp5ixDZwcR0olmiw6r1KSi8HEC0kevDRHLUwvaoX6dscyNQLeQiIEMp9WrQ4ZFbuI1COfilS5lrmjJUMIPNSJb5bAXRRP8DK1ZWpcuIY-D7AsBCjk56Tgthn51YggrJrMrLvv0smQndo7rmdiIIFoal8NddkpmAI~S31r5bktI2NYjXES71~gcyFol1fFVb-QkzI30UT6GOhWLCON~Hdw__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q
PMID28323930	Lam et al. (2017)	Lam17_Ki67.Ins.cells	Ki67.Ins.cells	%	Quantification of beta cell proliferation by Ki67+ staining and reported as % of total cells	beta cell neogenesis	cell	type B pancreatic cell	islet of Langerhans	0	1	Yes	NA		MP:0011818	abnormal pancreatic beta cell proliferation			0	0			immunostaining	Lam et al. (2017)				Supplemental Table 7: Individual ?-cell and acinar cell proliferation from non-diabetic pancreata. & Supplemental Table 8: Individual ?-cell and acinar cell proliferation from T1D pancreta.	https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jcem/102/8/10.1210_jc.2016-3806/1/jc.2016-3806_Supplemental_Table_1-14.xlsx?Expires=1521155148&Signature=Gl0xp87IMGbQE1zah6aRz-lHuJU6ffk0HGoiq-oF6VVKtfJMtBt9MkR9IKlsXA52~vD7IHsYpcLfBqQlABbYBTEF3suFfag97PErpOI4RGmtWWyEmBHAL2Js~KJ9hkRlQrp5ixDZwcR0olmiw6r1KSi8HEC0kevDRHLUwvaoX6dscyNQLeQiIEMp9WrQ4ZFbuI1COfilS5lrmjJUMIPNSJb5bAXRRP8DK1ZWpcuIY-D7AsBCjk56Tgthn51YggrJrMrLvv0smQndo7rmdiIIFoal8NddkpmAI~S31r5bktI2NYjXES71~gcyFol1fFVb-QkzI30UT6GOhWLCON~Hdw__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q
PMID28323930	Lam et al. (2017)	Lam17_Arx.cells	Arx.cells	count	Count of acinar cells		cell	pancreatic acinar cell	islet of Langerhans	0	1	Yes	NA		MP:0009155	pancreatic acinar hyperplasia			0	0			immunostaining	Lam et al. (2017)				Supplemental Table 7: Individual ?-cell and acinar cell proliferation from non-diabetic pancreata. & Supplemental Table 8: Individual ?-cell and acinar cell proliferation from T1D pancreta.	https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jcem/102/8/10.1210_jc.2016-3806/1/jc.2016-3806_Supplemental_Table_1-14.xlsx?Expires=1521155148&Signature=Gl0xp87IMGbQE1zah6aRz-lHuJU6ffk0HGoiq-oF6VVKtfJMtBt9MkR9IKlsXA52~vD7IHsYpcLfBqQlABbYBTEF3suFfag97PErpOI4RGmtWWyEmBHAL2Js~KJ9hkRlQrp5ixDZwcR0olmiw6r1KSi8HEC0kevDRHLUwvaoX6dscyNQLeQiIEMp9WrQ4ZFbuI1COfilS5lrmjJUMIPNSJb5bAXRRP8DK1ZWpcuIY-D7AsBCjk56Tgthn51YggrJrMrLvv0smQndo7rmdiIIFoal8NddkpmAI~S31r5bktI2NYjXES71~gcyFol1fFVb-QkzI30UT6GOhWLCON~Hdw__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q
PMID28323930	Lam et al. (2017)	Lam17_Ki67.Arx.cells	Ki67.Arx.cells	%	Quantification of acinar cell proliferation by Ki67+ staining and reported as % of total cells	beta cell neogenesis	cell	pancreatic acinar cell	islet of Langerhans	0	1	Yes	NA		MP:0009155	pancreatic acinar hyperplasia			0	0			immunostaining	Lam et al. (2017)				Supplemental Table 7: Individual ?-cell and acinar cell proliferation from non-diabetic pancreata. & Supplemental Table 8: Individual ?-cell and acinar cell proliferation from T1D pancreta.	https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jcem/102/8/10.1210_jc.2016-3806/1/jc.2016-3806_Supplemental_Table_1-14.xlsx?Expires=1521155148&Signature=Gl0xp87IMGbQE1zah6aRz-lHuJU6ffk0HGoiq-oF6VVKtfJMtBt9MkR9IKlsXA52~vD7IHsYpcLfBqQlABbYBTEF3suFfag97PErpOI4RGmtWWyEmBHAL2Js~KJ9hkRlQrp5ixDZwcR0olmiw6r1KSi8HEC0kevDRHLUwvaoX6dscyNQLeQiIEMp9WrQ4ZFbuI1COfilS5lrmjJUMIPNSJb5bAXRRP8DK1ZWpcuIY-D7AsBCjk56Tgthn51YggrJrMrLvv0smQndo7rmdiIIFoal8NddkpmAI~S31r5bktI2NYjXES71~gcyFol1fFVb-QkzI30UT6GOhWLCON~Hdw__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q
PMID28323930	Lam et al. (2017)	Lam17_Nkx61.Arx.cells	Nkx61.Arx.cells	%	Quantification of islet ductal neogenesis by staining for Nkx6.1+/Arx+ cells and reported as % total cells	beta cell neogenesis	cell	pancreatic ductal cell	islet of Langerhans	0	1	Yes	NA						0	0			immunostaining	Lam et al. (2017)	Islet images were classified into three possible categories: (1) solitary insulin-positive ? cell in duct; (2) insulin-positive islet in duct; and (3) insulin-positive islets not associated with ducts. Results were quantified per individual and expressed as percent total islets.			Supplemental Table 12: No evidence of ?-cell Neogenesis in T1D Pancreata.	https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jcem/102/8/10.1210_jc.2016-3806/1/jc.2016-3806_Supplemental_Table_1-14.xlsx?Expires=1521155148&Signature=Gl0xp87IMGbQE1zah6aRz-lHuJU6ffk0HGoiq-oF6VVKtfJMtBt9MkR9IKlsXA52~vD7IHsYpcLfBqQlABbYBTEF3suFfag97PErpOI4RGmtWWyEmBHAL2Js~KJ9hkRlQrp5ixDZwcR0olmiw6r1KSi8HEC0kevDRHLUwvaoX6dscyNQLeQiIEMp9WrQ4ZFbuI1COfilS5lrmjJUMIPNSJb5bAXRRP8DK1ZWpcuIY-D7AsBCjk56Tgthn51YggrJrMrLvv0smQndo7rmdiIIFoal8NddkpmAI~S31r5bktI2NYjXES71~gcyFol1fFVb-QkzI30UT6GOhWLCON~Hdw__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q
PMID28323930	Lam et al. (2017)	Lam17_Ins.Gcg.cells	Ins.Gcg.cells	count	Number of insulin-glucagon coexpressing cells	beta cell dedifferentiation	cell	other	islet of Langerhans	0	1	Yes	NA						0	0			immunostaining	Lam et al. (2017)				Supplemental Table 13: Insulin-glucagon coexpressing cells from non-diabetic and T1D samples.	https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jcem/102/8/10.1210_jc.2016-3806/1/jc.2016-3806_Supplemental_Table_1-14.xlsx?Expires=1521155148&Signature=Gl0xp87IMGbQE1zah6aRz-lHuJU6ffk0HGoiq-oF6VVKtfJMtBt9MkR9IKlsXA52~vD7IHsYpcLfBqQlABbYBTEF3suFfag97PErpOI4RGmtWWyEmBHAL2Js~KJ9hkRlQrp5ixDZwcR0olmiw6r1KSi8HEC0kevDRHLUwvaoX6dscyNQLeQiIEMp9WrQ4ZFbuI1COfilS5lrmjJUMIPNSJb5bAXRRP8DK1ZWpcuIY-D7AsBCjk56Tgthn51YggrJrMrLvv0smQndo7rmdiIIFoal8NddkpmAI~S31r5bktI2NYjXES71~gcyFol1fFVb-QkzI30UT6GOhWLCON~Hdw__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q
PMID28323930	Lam et al. (2017)	Lam17_beta.area	beta.area	%	Beta cell area reported as % total pancreas sections analyzed		cell	type B pancreatic cell	islet of Langerhans	0	1	Yes	NA		MP:0020578	abnormal pancreatic beta cell number			1	1			immunostaining	Lam et al. (2017)				Supplemental Table 4: Non-diabetic beta-cell area and mass. & Supplemental Table 5: T1D beta-cell area and mass.	https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jcem/102/8/10.1210_jc.2016-3806/1/jc.2016-3806_Supplemental_Table_1-14.xlsx?Expires=1521155148&Signature=Gl0xp87IMGbQE1zah6aRz-lHuJU6ffk0HGoiq-oF6VVKtfJMtBt9MkR9IKlsXA52~vD7IHsYpcLfBqQlABbYBTEF3suFfag97PErpOI4RGmtWWyEmBHAL2Js~KJ9hkRlQrp5ixDZwcR0olmiw6r1KSi8HEC0kevDRHLUwvaoX6dscyNQLeQiIEMp9WrQ4ZFbuI1COfilS5lrmjJUMIPNSJb5bAXRRP8DK1ZWpcuIY-D7AsBCjk56Tgthn51YggrJrMrLvv0smQndo7rmdiIIFoal8NddkpmAI~S31r5bktI2NYjXES71~gcyFol1fFVb-QkzI30UT6GOhWLCON~Hdw__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q
PMID28323930	Lam et al. (2017)	Lam17_beta.mass	beta.mass	g	Beta cell mass in grams		cell	type B pancreatic cell	islet of Langerhans	0	1	Yes	NA		MP:0009112	abnormal pancreatic beta cell mass			1	1			immunostaining	Lam et al. (2017)	Calculated from area stained and adjusted by known pancreas weight.			Supplemental Table 4: Non-diabetic beta-cell area and mass. & Supplemental Table 5: T1D beta-cell area and mass.	https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jcem/102/8/10.1210_jc.2016-3806/1/jc.2016-3806_Supplemental_Table_1-14.xlsx?Expires=1521155148&Signature=Gl0xp87IMGbQE1zah6aRz-lHuJU6ffk0HGoiq-oF6VVKtfJMtBt9MkR9IKlsXA52~vD7IHsYpcLfBqQlABbYBTEF3suFfag97PErpOI4RGmtWWyEmBHAL2Js~KJ9hkRlQrp5ixDZwcR0olmiw6r1KSi8HEC0kevDRHLUwvaoX6dscyNQLeQiIEMp9WrQ4ZFbuI1COfilS5lrmjJUMIPNSJb5bAXRRP8DK1ZWpcuIY-D7AsBCjk56Tgthn51YggrJrMrLvv0smQndo7rmdiIIFoal8NddkpmAI~S31r5bktI2NYjXES71~gcyFol1fFVb-QkzI30UT6GOhWLCON~Hdw__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q
PMID28213757	Willcox et al. (2017)	Willcox17_germinal.c.freq	germinal.c.freq	%	Percent follicles with germinal center		cell	germinal center	pancreatic lymph node	0	1	Contact authors	NA						1	1			immunostaining	Willcox et al. (2017)				Fig. 3	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487689/figure/Fig3/
PMID28154952	Martin et al. (2017)	Martin17_Nitrotyrosine	Nitrotyrosine	%	Nitrotyrosine expression as percentage of insulin-positive islets with nitrotyrosine staining		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA						1	1	Nitrotyrosine immunostaining is independent of the presence and severity of insulitis		immunostaining	Martin et al. (2017)				Fig 4: Non-diabetic autoantibody-negative nPOD cases showing the percentage of insulin-positive islets with nitrotyrosine. & Fig 6: Non-diabetic autoantibody-positive nPOD cases showing the percentage of insulin-positive islets with nitrotyrosine.	https://link.springer.com/article/10.1007%2Fs00418-016-1533-5#Fig4|https://link.springer.com/article/10.1007%2Fs00418-016-1533-5#Fig6
PMID28137793	Rodriguez-Calvo et al. (2017)	RodriguezCalvo17_Ins	Ins	%	Measured by staining and reported as % positive area		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Rodriguez-Calvo et al. (2017)					http://diabetes.diabetesjournals.org/content/diabetes/66/5/1334/F1.large.jpg?width=800&height=600&carousel=1
PMID28137793	Rodriguez-Calvo et al. (2017)	RodriguezCalvo17_Proins	Proins	%	Measured by staining and reported as % positive area		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							1			immunostaining	Rodriguez-Calvo et al. (2017)					http://diabetes.diabetesjournals.org/content/diabetes/66/5/1334/F1.large.jpg?width=800&height=600&carousel=1
PMID28137793	Rodriguez-Calvo et al. (2017)	RodriguezCalvo17_Gcg	Gcg	%	Measured by staining and reported as % positive area		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Rodriguez-Calvo et al. (2017)					http://diabetes.diabetesjournals.org/content/diabetes/66/5/1334/F1.large.jpg?width=800&height=600&carousel=1
PMID28119693	Graves et al. (2016)	Graves16_BD2	BD2	Delta CT value [gene of interest (GOI)—18S]	Expression of antimicrobial peptide beta-defensin 2 (BD-2) in duodenal tissue		transcript	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222791/figure/F1/
PMID28119693	Graves et al. (2016)	Graves16_IL17C	IL17C	Delta CT value [gene of interest (GOI)—18S]	Expression of antimicrobial peptide beta-defensin 2 (BD-2) in duodenal tissue		transcript	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222791/figure/F1/
PMID28119693	Graves et al. (2016)	Graves16_TSLP	TSLP	Delta CT value [gene of interest (GOI)—18S]	Expression of thymic stromal lymphopoietin (TSLP) in duodenal tissue		transcript	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222791/figure/F1/
PMID28119693	Graves et al. (2016)	Graves16_TLR5	TLR5	Delta CT value [gene of interest (GOI)—18S]	Expression of antimicrobial peptide beta-defensin 2 (BD-2) in duodenal tissue		transcript	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222791/figure/F1/
PMID28119693	Graves et al. (2016)	Graves16_IL10	IL10	pg/ml	Protein expression of IL-10 in duodenal tissue		protein	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222791/figure/F1/
PMID28119693	Graves et al. (2016)	Graves16_freq.CD3	freq.CD3	% viable CD3+	Frequency of CD3+ T-cells in duodenal tissue		cell	T cell	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222791/figure/F3/
PMID28119693	Graves et al. (2016)	Graves16_freq.CD4	freq.CD4	% CD4+ (of alpha/beta+ viable CD3+)	Frequency of CD4+ T-cells in duodenal tissue		cell	CD4-positive, alpha-beta T cell	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222791/figure/F3/
PMID28119693	Graves et al. (2016)	Graves16_freq.CD8	freq.CD8	% CD8+ (of alpha/beta+ viable CD3+)	Frequency of CD8+ T-cells in duodenal tissue		cell	CD8-positive, alpha-beta T cell	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222791/figure/F3/
PMID28119693	Graves et al. (2016)	Graves16_freq.Treg	freq.Treg	% CD4+FOXP3+	Frequency of CD4+FOXP3+ T-cells (Tregs) in duodenal tissue		cell	regulatory T cell	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222791/figure/F3/
PMID28119693	Graves et al. (2016)	Graves16_freq.Th1	freq.Th1	% CD4+CXCR3+	Frequency of CD4+CXCR3+ (Th1) T-cells in duodenal tissue		cell	T-helper 1 cell	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222791/figure/F3/
PMID28119693	Graves et al. (2016)	Graves16_freq.Tc1	freq.Tc1	% CD8+CXCR3+	Frequency of CD8+CXCR3+ (Tc1) T-cells in duodenal tissue		cell	Tc1 cell	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222791/figure/F3/
PMID28119693	Graves et al. (2016)	Graves16_freq.ILC1	freq.ILC1	% CD127+NKp44−CD117− cells	Frequency of type 1 innate lymphoid cells (ILC1) of in duodenal tissues		cell	ILC1	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222791/figure/F2/
PMID28119693	Graves et al. (2016)	Graves16_freq.ILC3	freq.ILC3	% CD127+CD117+NKp44+/− cells	Frequency of ILC3 cells in duodenal tissues		cell	group 3 innate lymphoid cell	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222791/figure/F2/
PMID28119693	Graves et al. (2016)	Graves16_BD2.IEC	BD2.IEC	Delta CT value [gene of interest (GOI)—18S]	Expression of BD-2 in unstimulated intestinal epithelial cell cultures		transcript	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					
PMID28119693	Graves et al. (2016)	Graves16_IL17C.IEC	IL17C.IEC	Delta CT value [gene of interest (GOI)—18S]	Expression of IL-17C in unstimulated intestinal epithelial cell cultures		transcript	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					
PMID28119693	Graves et al. (2016)	Graves16_TSLP.IEC	TSLP.IEC	Delta CT value [gene of interest (GOI)—18S]	Expression of TSLP in unstimulated intestinal epithelial cell cultures		transcript	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					
PMID28119693	Graves et al. (2016)	Graves16_TLR5.IEC	TLR5.IEC	Delta CT value [gene of interest (GOI)—18S]	Expression in ofTLR5 unstimulated intestinal epithelial cell cultures		transcript	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					
PMID28119693	Graves et al. (2016)	Graves16_IL10.IEC	IL10.IEC	Delta CT value [gene of interest (GOI)—18S]	Expression of IL10 in unstimulated intestinal epithelial cell cultures		transcript	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					
PMID28119693	Graves et al. (2016)	Graves16_BD2.IECx	BD2.IECx	Delta CT value [gene of interest (GOI)—18S]	Expression of BD-2 in conditioned intestinal epithelial cell cultures		transcript	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					
PMID28119693	Graves et al. (2016)	Graves16_IL17C.IECx	IL17C.IECx	Delta CT value [gene of interest (GOI)—18S]	Expression of IL-17C in conditioned intestinal epithelial cell cultures		transcript	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					
PMID28119693	Graves et al. (2016)	Graves16_TSLP.IECx	TSLP.IECx	Delta CT value [gene of interest (GOI)—18S]	Expression of TSLP in conditioned intestinal epithelial cell cultures		transcript	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					
PMID28119693	Graves et al. (2016)	Graves16_TLR5.IECx	TLR5.IECx	Delta CT value [gene of interest (GOI)—18S]	Expression of TLR5 in conditioned intestinal epithelial cell cultures		transcript	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					
PMID28119693	Graves et al. (2016)	Graves16_IL10.IECx	IL10.IECx	Delta CT value [gene of interest (GOI)—18S]	Expression of IL10 in conditioned intestinal epithelial cell cultures		transcript	duodenum	duodenum	0	1	Contact authors	NA							NA				Graves et al. (2016)					
PMID28094469	Kirk et al. (2017)	Kirk17_GLP1R.prct.acinar	GLP1R.prct.acinar	%	GLP-1R+ cells in or near ducts (% of total duct cells)		protein	pancreatic ductal cell	islet of Langerhans	0	1	Yes	NA						1	1			immunostaining	Kirk et al. (2017)	A software-based automated image analysis algorithm was used for quantitating intensities and area fractions of GLP-1R positive compartments.			Table 2: GLP-1R expression levels.	https://onlinelibrary.wiley.com/doi/epdf/10.1111/dom.12879
PMID28094469	Kirk et al. (2017)	Kirk17_GLP1R.prct.islets	GLP1R.prct.islets	%	GLP-1R+ cells in islets (% of total pancreas area)		protein	pancreatic ductal cell	islet of Langerhans	0	1	Yes	NA						1	1	Glucagon-like peptide-1 (GLP-1) has beta-cell protective effects and can be assessed by a new monoclonal antibody in pancreatic tissue		immunostaining	Kirk et al. (2017)				Table 2: GLP-1R expression levels.	https://onlinelibrary.wiley.com/doi/epdf/10.1111/dom.12879
PMID28094469	Kirk et al. (2017)	Kirk17_GLP1R.acinar	GLP1R.acinar		Average intensity of GLP-1R+ acinar cells		protein	pancreatic acinar cell	islet of Langerhans	0	1	Yes	NA						1	1			immunostaining	Kirk et al. (2017)				Table 2: GLP-1R expression levels.	https://onlinelibrary.wiley.com/doi/epdf/10.1111/dom.12879
PMID28094469	Kirk et al. (2017)	Kirk17_GLP1R.islet	GLP1R.islet		Average intensity of GLP-1R+ cells in islets		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA						1	1			immunostaining	Kirk et al. (2017)				Table 2: GLP-1R expression levels.	https://onlinelibrary.wiley.com/doi/epdf/10.1111/dom.12879
PMID27942583	Seay et al. (2016)	Seay16_Immunosequencing	Immunosequencing		High-throughput immunosequencing data		peptide			1	2000	Yes	NA						1	1			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies			nPOD TCR/BCR Search	http://clonesearch.jdrfnpod.org/
PMID27942583	Seay et al. (2016)	Seay16_Bcell.PBMC.PC	Bcell.PBMC.PC		Productive clonality (PC) of purified B cells from blood		phenotype	B cell	blood	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_Bcell.Spleen.PC	Bcell.Spleen.PC		Productive clonality (PC) of purified B cells from spleen		phenotype	B cell	spleen	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_Bcell.iLN.PC	Bcell.iLN.PC		Productive clonality (PC) of purified B cells from “irrelevant” nonpancreatic draining lymph nodes		phenotype	B cell	mesenteric lymph node	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_Bcell.pLN.PC	Bcell.pLN.PC		Productive clonality (PC) of purified B cells from pancreatic draining lymph nodes		phenotype	B cell	pancreatic lymph node	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_CD4Tcell.Intraislet.PC	CD4Tcell.Intraislet.PC		Productive clonality (PC) of purified CD4 T cells from islet tissue		phenotype	CD4-positive, alpha-beta T cell	islet of Langerhans	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_CD8Tcell.Intraislet.PC	CD8Tcell.Intraislet.PC		Productive clonality (PC) of purified CD8 T cells from islet tissue		phenotype	CD8-positive, alpha-beta T cell	islet of Langerhans	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_CD8Tcell.PBMC.PC	CD8Tcell.PBMC.PC		Productive clonality (PC) of purified CD8 T cells from blood		phenotype	CD8-positive, alpha-beta T cell	blood	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_CD8Tcell.Spleen.PC	CD8Tcell.Spleen.PC		Productive clonality (PC) of purified CD8 T cells from spleen		phenotype	CD8-positive, alpha-beta T cell	spleen	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_CD8Tcell.iLN.PC	CD8Tcell.iLN.PC		Productive clonality (PC) of purified CD8 T cells from “irrelevant” nonpancreatic draining lymph nodes		phenotype	CD8-positive, alpha-beta T cell	mesenteric lymph node	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_CD8Tcell.pLN.PC	CD8Tcell.pLN.PC		Productive clonality (PC) of purified CD8 T cells from pancreatic draining lymph nodes		phenotype	CD8-positive, alpha-beta T cell	pancreatic lymph node	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_Tconv.PBMC.PC	Tconv.PBMC.PC		Productive clonality (PC) of purified CD4+ conventional T cells from blood		phenotype	CD4-positive, alpha-beta T cell	blood	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_Tconv.Spleen.PC	Tconv.Spleen.PC		Productive clonality (PC) of purified CD4+ conventional T cells from spleen		phenotype	CD4-positive, alpha-beta T cell	spleen	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_Tconv.iLN.PC	Tconv.iLN.PC		Productive clonality (PC) of purified CD4+ conventional T cells from “irrelevant” nonpancreatic draining lymph nodes		phenotype	CD4-positive, alpha-beta T cell	mesenteric lymph node	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_Tconv.pLN.PC	Tconv.pLN.PC		Productive clonality (PC) of purified CD4+ conventional T cells from pancreatic draining lymph nodes		phenotype	CD4-positive, alpha-beta T cell	pancreatic lymph node	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_Treg.PBMC.PC	Treg.PBMC.PC		Productive clonality (PC) of CD4+ regulatory T cells from blood		phenotype	regulatory T cell	blood	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_Treg.Spleen.PC	Treg.Spleen.PC		Productive clonality (PC) of CD4+ regulatory T cells from spleen		phenotype	regulatory T cell	spleen	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_Treg.iLN.PC	Treg.iLN.PC		Productive clonality (PC) of CD4+ regulatory T cells from “irrelevant” nonpancreatic draining lymph nodes		phenotype	regulatory T cell	mesenteric lymph node	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27942583	Seay et al. (2016)	Seay16_Treg.pLN.PC	Treg.pLN.PC		Productive clonality (PC) of CD4+ regulatory T cells from pancreatic lymph nodes		phenotype	regulatory T cell	pancreatic lymph node	0	1	Yes	NA							NA			DNA sequencing assay	Seay et al. (2016)	immunoSEQ assay from Adaptive Biotechnologies				
PMID27813705	Moin et al. (2016)	Moin16_Ki67.PDG	Ki67.PDG	%	PDG Cell proliferation (% Ki67+ PDG cells)	beta cell neogenesis	cell	pancreatic ductal cell	islet of Langerhans	0	1	Yes	NA		MP:0009143	abnormal pancreatic duct morphology			1	1			immunostaining	Moin et al. (2016)				Table 1: Characteristics of Human Subjects With and Without T1D	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413103/table/T1/
PMID27813705	Moin et al. (2016)	Moin16_Ki67.interPDG	Ki67.interPDG	%	Interlobular duct cell proliferation (% Ki67+ interlobular duct cells)	beta cell neogenesis	cell	pancreatic ductal cell	islet of Langerhans	0	1	Yes	NA							1			immunostaining	Moin et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413103/figure/F2/
PMID27813705	Moin et al. (2016)	Moin16_Ki67.intraPDG	Ki67.intraPDG	%	Intralobular duct cell proliferation (% Ki67+ intralobular duct cells)	beta cell neogenesis	cell	pancreatic ductal cell	islet of Langerhans	0	1	Yes	NA							1			immunostaining	Moin et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413103/figure/F2/
PMID27813705	Moin et al. (2016)	Moin16_Ins.interPDG	Ins.interPDG	%	Beta cell neogenesis from interlobular duct cells (% Ins+ interlobular duct cells)	beta cell neogenesis	cell	pancreatic ductal cell	islet of Langerhans	0	1	Yes	NA							1			immunostaining	Moin et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413103/figure/F2/
PMID27813705	Moin et al. (2016)	Moin16_Ins.intraPDG	Ins.intraPDG	%	Beta cell neogenesis from intralobular duct cells (% Ins+ intralobular duct cells)	beta cell neogenesis	cell	pancreatic ductal cell	islet of Langerhans	0	1	Yes	NA							1			immunostaining	Moin et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413103/figure/F2/
PMID27813705	Moin et al. (2016)	Moin16_Sox9.PDG	Sox9.PDG	%	Presence of pancreatic progenitors in pancreatic duct glands (% Sox9+ PDG cells)	beta cell neogenesis	cell	pancreatic duct	pancreas	0	1	Contact authors	NA						0	0			immunostaining	Moin et al. (2016)					
PMID27813705	Moin et al. (2016)	Moin16_Gata4.PDG	Gata4.PDG	%	Presence of pancreatic progenitors in pancreatic duct glands (%GATA4+ PDG cells)	beta cell neogenesis	cell	pancreatic duct	pancreas	0	1	Contact authors	NA						0	0			immunostaining	Moin et al. (2016)					
PMID27809303	Piran et al. (2016)	Piran16_Par2	Par2		PAR2 expression		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA						0	1			immunostaining	Piran et al. (2016)					
PMID27798614	Babon et al. (2016)	Babon16_Autoreactivity	Autoreactivity	IFNg pg/mL	Autoreactivity of CD4+ and CD8+ T cell lines and clones sorted or directly grown from islets from donors, measured as production of IFNgamma		phenotype	CD8-positive, alpha-beta T cell	islet of Langerhans	1	15	Contact authors	NA				EFO:0008165	interferon gamma measurement	1	1			chemokine assay	Babon et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5140746/figure/F2/
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.A1	HLA.A1	Normalized gene expression	Relative RNA expression of HLA.A1	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3105		MP:0001836	abnormal antigen presentation via MHC class I			1	1	No statistically significant differences between T1D vs Controls		microarray	Wu et al. (2012)	Using the Affymetrix Human Gene 2.0 ST array, CEL files were generated from both control and type 1 diabetic donors, as previously described [24]. Raw signal-intensity values from Affymetrix spike-in controls demonstrated that array hybridisation had been successful (i.e. bioB<bioC<bioD<Cre). Data quality was verified by measuring the positive vs negative area under the curve. Raw signal-intensity values from all arrays were robust multichip average background corrected, quantile normalised, median polish summarised and log2 transformed [25–27]. NetAffx-determined probe-set annotations for HLA genes (Affymetrix) were re-mapped according to RefSeq, release 73 (15 November 2015; see ftp://ftp.ncbi.nlm.nih.gov/refseq/release/release-catalog/archive/). For each HLA gene, where multiple mappings were possible (i.e. HLA-A, -B, -C and -F), probe sets were annotated according to eight major haplotypes incorporated into the human genome assembly, as previously described [28]. Because probe sets shared mappings, it was not possible to identify HLA subtypes uniquely using this gene chip; rather, transcript clusters were used to examine changes in global gene expression. Processing was carried out using the Partek Genomics Suite, version 6.5 (Partek, St Louis, MO, USA).			ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.A2	HLA.A2	Normalized gene expression	Relative RNA expression of HLA.A2	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3105		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.A3	HLA.A3	Normalized gene expression	Relative RNA expression of HLA.A3	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3105		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.A4	HLA.A4	Normalized gene expression	Relative RNA expression of HLA.A4	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3105		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.A5	HLA.A5	Normalized gene expression	Relative RNA expression of HLA.A5	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3105		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.A6	HLA.A6	Normalized gene expression	Relative RNA expression of HLA.A6	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3105		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.A7	HLA.A7	Normalized gene expression	Relative RNA expression of HLA.A7	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3105		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.A8	HLA.A8	Normalized gene expression	Relative RNA expression of HLA.A7	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3105		MP:0001836	abnormal antigen presentation via MHC class I			1	1	No statistically significant differences between T1D vs Controls		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.B1	HLA.B1	Normalized gene expression	Relative RNA expression of HLA.B1	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3106		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.B2	HLA.B2	Normalized gene expression	Relative RNA expression of HLA.B2	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3106		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.B3	HLA.B3	Normalized gene expression	Relative RNA expression of HLA.B3	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3106		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.B4	HLA.B4	Normalized gene expression	Relative RNA expression of HLA.B4	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3106		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.B5	HLA.B5	Normalized gene expression	Relative RNA expression of HLA.B5	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3106		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.B6	HLA.B6	Normalized gene expression	Relative RNA expression of HLA.B6	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3106		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.C1	HLA.C1	Normalized gene expression	Relative RNA expression of HLA.C1	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3107		MP:0001836	abnormal antigen presentation via MHC class I			1	1	No statistically significant differences between T1D vs Controls		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.C2	HLA.C2	Normalized gene expression	Relative RNA expression of HLA.C2	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3107		MP:0001836	abnormal antigen presentation via MHC class I			1	1	No statistically significant differences between T1D vs Controls		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.C3	HLA.C3	Normalized gene expression	Relative RNA expression of HLA.C3	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3107		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.C4	HLA.C4	Normalized gene expression	Relative RNA expression of HLA.C4	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3107		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.C5	HLA.C5	Normalized gene expression	Relative RNA expression of HLA.C5	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3107		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.C6	HLA.C6	Normalized gene expression	Relative RNA expression of HLA.C6	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3107		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.C7	HLA.C7	Normalized gene expression	Relative RNA expression of HLA.C7	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3107		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.F1	HLA.F1	Normalized gene expression	Relative RNA expression of HLA.F1	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3134		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.F2	HLA.F2	Normalized gene expression	Relative RNA expression of HLA.F2	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3134		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.F3	HLA.F3	Normalized gene expression	Relative RNA expression of HLA.F3	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3134		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.F4	HLA.F4	Normalized gene expression	Relative RNA expression of HLA.F4	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3134		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.F5	HLA.F5	Normalized gene expression	Relative RNA expression of HLA.F5	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3134		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.F6	HLA.F6	Normalized gene expression	Relative RNA expression of HLA.F6	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3134		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Hyperexpression observed in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_HLA.F7	HLA.F7	Normalized gene expression	Relative RNA expression of HLA.F7	HLA	transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	3134		MP:0001836	abnormal antigen presentation via MHC class I			1	1	No statistically significant differences between T1D vs Controls		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_B2M	B2M	Normalized gene expression	Relative RNA expression of B2M		transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	567		MP:0001836	abnormal antigen presentation via MHC class I	EFO:0005197	beta-2 microglobulin measurement	0	1	Expression of beta2-microglobulin (a second component required for the generation of functional HLA class I complexes) elevated in T1D		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_NLRC5	NLRC5	Normalized gene expression	Relative RNA expression of NLRC5		transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	84166						0	0	No statistically significant differences between T1D vs controls		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_STAT1	STAT1	Normalized gene expression	Relative RNA expression of STAT1		transcript	islet of Langerhans	islet of Langerhans	0	1	Yes	6772						1	1	Higher in T1D than controls; positive correlation between STAT1 and HLA-ABC expression; decreases with disease duration		microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_IHC.score	IHC.score	score	Overall score of overall HLA expression in islets		phenotype	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0001836	abnormal antigen presentation via MHC class I			1	1	Higher in T1D than controls	0=normal expression,1=elevated expression,2=hyperexpression	microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27506584	Richardson et al. (2016)	Richardson16_ICI.score	ICI.score	score	Overall score of insulin immunopositivity in islets (number of residual ICIs in the nearest available block)		phenotype	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0020578	abnormal pancreatic beta cell number			1	1	Variable but generally lower insulin immunopositivity in T1D vs controls	 (+++ >20 ICIs; ++ 10-20 ICIs; + 1-10 ICIs, -No ICIs)	microarray	Wu et al. (2012)				ESM Figure 5: Heat map of relative RNA expression of the HLA-A, B, C , F, beta2M, STAT1 genes examined in nPODcontrols and nPOD Type 1 diabetes patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042874/bin/125_2016_4067_MOESM1_ESM.pdf
PMID27300574	Moin et al. (2016)	Moin16_CgA.cells	CgA.cells	% CPHN cells in islets	Frequency of chromogranin-positive, hormone-negative (CPHN) cells in islets		cell	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA						1	1			immunostaining	Moin et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010569/figure/F2/
PMID27300574	Moin et al. (2016)	Moin16_CgA.cluster	CgA.cluster	% CPHN in clusters	Frequency of chromogranin-positive, hormone-negative (CPHN) cells in scattered clusters of endocrine cells		cell	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA						1	1			immunostaining	Moin et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010569/figure/F2/
PMID27300574	Moin et al. (2016)	Moin16_CgA.section	CgA.section	count of CPHN cells/mm^2 of pancreas section	Frequency of chromogranin-positive, hormone-negative (CPHN) cells in scattered clusters of endocrine cells		cell	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA						1	1			immunostaining	Moin et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010569/figure/F2/
PMID27284108	Phelps et al. (2016)	Phelps16_GAD65.ratio	GAD65.ratio	ratio	GAD65 localization as Golgi:Cell mean fluorescence intensity (MFI) ratio		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	2572						1	1	Distribution of GAD65 changes under ER stress – appears to accumulate in Golgi		immunostaining	Phelps et al. (2016)	The ratio of GAD65 mean fluorescence intensity (MFI) in the Golgi compartment and post-Golgi vesicles compared with the rest of the cytosol was calculated with a custom ImageJ macro. Individual B-cells in a given field of view were identified and outlined by hand. For each cell, the macro automatically defined a region of interest (ROI) outlining the Golgi compartment, identified by giantin costain or by characteristic morphology and brightness thresholding of GAD65 stain, and GAD65+ vesicles, identified by brightness thresholding of GAD65+ bright puncta. A second ROI defined the remainder of the cell, excluding the Golgi, GAD65+ vesicles, and nucleus. GAD65 Golgi accumulation was reported as the ratio of MFI for the two ROIs.			Supplementary Table 1 & Supplementary Table 2 & Supplementary Table 3	http://diabetes.diabetesjournals.org/highwire/filestream/75457/field_highwire_adjunct_files/0/DB160180SupplementaryData.pdf
PMID26950362	Helman et al. (2016)	Helman16_p16	p16		staining intensity		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Helman et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546206/bin/NIHMS872711-supplement-Supplemental_Tables.pdf
PMID26950362	Helman et al. (2016)	Helman16_Cox17	Cox17		staining intensity		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Helman et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546206/bin/NIHMS872711-supplement-Supplemental_Tables.pdf
PMID26950362	Helman et al. (2016)	Helman16_pS6	pS6		staining intensity		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Helman et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546206/bin/NIHMS872711-supplement-Supplemental_Tables.pdf
PMID26950362	Helman et al. (2016)	Helman16_Ndufb5	Ndufb5		staining intensity		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Helman et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546206/bin/NIHMS872711-supplement-Supplemental_Tables.pdf
PMID26950362	Helman et al. (2016)	Helman16_Atp5a	Atp5a		staining intensity		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Helman et al. (2016)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546206/bin/NIHMS872711-supplement-Supplemental_Tables.pdf
PMID26935967	Liu et al. (2016)	Liu16_Proteomics	Proteomics	NA	Proteomics of pancreatic head region tissues, expression values for 5357 proteins		protein	exocrine pancreas	exocrine pancreas	1	5357	Yes	NA							1	Among the 5357 (1% false discovery rate) confidently identified proteins, 145 showed statistically significant dysregulation between T1D and healthy subjects		TMT10;LC-MS	Liu et al. (2016)	Approximately 30 mg of tissue from each sample were processed for TMT10-based isobaric labeling and multidimensional LC-MS/MS was used for peptide analysis.			Table S1: 5368 protein groups identified in pancreatic tissue.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893790/bin/NIHMS788696-supplement-supplemental_information.pdf
PMID26858360	Leete et al. (2016)	Leete16_CD20.cat	CD20.cat	[Lo,Hi]	Ratio of CD20+:CD4+ cells in inflamed islets, reported as 0 = CD20Lo or 1 = CD20Hi		cell	B cell|CD4-positive, alpha-beta T cell	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis			1	1			immunostaining	Arif et al. (2014)					http://diabetes.diabetesjournals.org/content/65/5/1362.long
PMID26581594	Campbell-Thompson et al. (2016)	CampbellThompson16_InsNeg.CD3Pos.prct	InsNeg.CD3Pos.prct		Percent of islets counted that are insulin-negative and CD3-positive		cell	T cell	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Campbell-Thompson et al. (2016)	Multiple slide sections were reviewed from each donor pancreas, and islets were counted by insulin immunopositivity (Ins+, Ins−) and insulitis status (CD3−, CD3+). Screening for insulitic islets was performed on CD3+ glucagon–stained sections. An islet was defined as ≥10 α-cells. Insulitis was defined as an islet with six or more CD3+ cells immediately adjacent to or within the islet with three or more islets per pancreas section.		Percent was calculated from original count data.	Table 1: Insulitis frequency in donors	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764143/table/T1/
PMID26581594	Campbell-Thompson et al. (2016)	CampbellThompson16_InsPos.CD3Pos.prct	InsPos.CD3Pos.prct		Percent of islets counted that are insulin-positive and CD3-positive		cell	T cell	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Campbell-Thompson et al. (2016)	Multiple slide sections were reviewed from each donor pancreas, and islets were counted by insulin immunopositivity (Ins+, Ins−) and insulitis status (CD3−, CD3+). Screening for insulitic islets was performed on CD3+ glucagon–stained sections. An islet was defined as ≥10 α-cells. Insulitis was defined as an islet with six or more CD3+ cells immediately adjacent to or within the islet with three or more islets per pancreas section.		Percent was calculated from original count data.	Table 1: Insulitis frequency in donors	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764143/table/T1/
PMID26581594	Campbell-Thompson et al. (2016)	CampbellThompson16_InsNeg.CD3Neg.prct	InsNeg.CD3Neg.prct		Percent of islets counted that are insulin-negative and CD3-negative		cell	T cell	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Campbell-Thompson et al. (2016)	Multiple slide sections were reviewed from each donor pancreas, and islets were counted by insulin immunopositivity (Ins+, Ins−) and insulitis status (CD3−, CD3+). Screening for insulitic islets was performed on CD3+ glucagon–stained sections. An islet was defined as ≥10 α-cells. Insulitis was defined as an islet with six or more CD3+ cells immediately adjacent to or within the islet with three or more islets per pancreas section.		Percent was calculated from original count data.	Table 1: Insulitis frequency in donors	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764143/table/T1/
PMID26581594	Campbell-Thompson et al. (2016)	CampbellThompson16_InsPos.CD3Neg.prct	InsPos.CD3Neg.prct		Percent of islets counted that are insulin-positive and CD3-negative		cell	T cell	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Campbell-Thompson et al. (2016)	Multiple slide sections were reviewed from each donor pancreas, and islets were counted by insulin immunopositivity (Ins+, Ins−) and insulitis status (CD3−, CD3+)		Percent was calculated from original count data.	Table 1: Insulitis frequency in donors	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764143/table/T1/
PMID26581594	Campbell-Thompson et al. (2016)	CampbellThompson16_CD3.prct	CD3.prct	%	Percent of islets with insulitis (with six or more CD3+ cells)		cell	T cell	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Campbell-Thompson et al. (2016)	Calculated as sum insulitic islets: (Ins+ CD3+ and Ins− CD3+)/total islets		Percent was calculated from original count data.	Table 1: Insulitis frequency in donors	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764143/table/T1/
PMID26581594	Campbell-Thompson et al. (2016)	CampbellThompson16_beta.mass	beta.mass	g	Beta cell mass		cell	type B pancreatic cell	islet of Langerhans	0	1	Contact authors	NA							NA	B-cell mass was decreased in donors with T1D, regardless of insulitis status, compared with those without T1D; however, B-cell mass was significantly higher in T1D donors with insulitis compared with those without insulitis		immunostaining	Campbell-Thompson et al. (2016)			Percent was calculated from original count data.	Figure 6	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764143/figure/F6/
PMID26581594	Campbell-Thompson et al. (2016)	CampbellThompson16_alpha.mass	alpha.mass	g	Alpha cell mass		cell	pancreatic A cell	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Campbell-Thompson et al. (2016)	Numbers of CD45+, CD3+, CD20+, CD8+, and CD4+ cells were counted for each insulitic islet and averaged per donor (2–10 islets/donor).		Percent was calculated from original count data.	Figure 6	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764143/figure/F6/
PMID26581594	Campbell-Thompson et al. (2016)	CampbellThompson16_CD45.cells.islet	CD45.cells.islet		CD45+ cells per islet		cell	leukocyte	islet of Langerhans	0	1	Contact authors	NA		MP:0004031	insulitis				NA			immunostaining	Campbell-Thompson et al. (2016)	Numbers of CD45+, CD3+, CD20+, CD8+, and CD4+ cells were counted for each insulitic islet and averaged per donor (2–10 islets/donor).		Percent was calculated from original count data.	Figure 5	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764143/figure/F5/
PMID26581594	Campbell-Thompson et al. (2016)	CampbellThompson16_CD3.cells.islet	CD3.cells.islet		CD3+ cells per islet		cell	T cell	islet of Langerhans	0	1	Contact authors	NA		MP:0004031	insulitis				NA			immunostaining	Campbell-Thompson et al. (2016)	Numbers of CD45+, CD3+, CD20+, CD8+, and CD4+ cells were counted for each insulitic islet and averaged per donor (2–10 islets/donor).		Percent was calculated from original count data.	Figure 5	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764143/figure/F5/
PMID26581594	Campbell-Thompson et al. (2016)	CampbellThompson16_CD20.cells.islet	CD20.cells.islet		CD20+ cells per islet		cell	B cell	islet of Langerhans	0	1	Contact authors	NA		MP:0004031	insulitis				NA			immunostaining	Campbell-Thompson et al. (2016)	Numbers of CD45+, CD3+, CD20+, CD8+, and CD4+ cells were counted for each insulitic islet and averaged per donor (2–10 islets/donor).		Percent was calculated from original count data.	Figure 5	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764143/figure/F5/
PMID26581594	Campbell-Thompson et al. (2016)	CampbellThompson16_CD8.cells.islet	CD8.cells.islet		CD8+ cells per islet		cell	CD8-positive, alpha-beta T cell	islet of Langerhans	0	1	Contact authors	NA		MP:0004031	insulitis				NA			immunostaining	Campbell-Thompson et al. (2016)	Numbers of CD45+, CD3+, CD20+, CD8+, and CD4+ cells were counted for each insulitic islet and averaged per donor (2–10 islets/donor).		Percent was calculated from original count data.	Figure 5	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764143/figure/F5/
PMID26581594	Campbell-Thompson et al. (2016)	CampbellThompson16_CD4.cells.islet	CD4.cells.islet		CD4+ cells per islet		cell	CD4-positive, alpha-beta T cell	islet of Langerhans	0	1	Contact authors	NA		MP:0004031	insulitis				NA			immunostaining	Campbell-Thompson et al. (2016)	Numbers of CD45+, CD3+, CD20+, CD8+, and CD4+ cells were counted for each insulitic islet and averaged per donor (2–10 islets/donor).		Percent was calculated from original count data.	Figure 5	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764143/figure/F5/
PMID26076035	van der Meulen et al. (2015)	vanderMeulen15_Ucn3.score	Ucn3.score	[1-3]	Expression of Urocortin3 (UCN3) in beta cells, staining intensity category		protein	type B pancreatic cell	islet of Langerhans	0	1	Yes	114131							NA	Ucn3 is stored and co-released with insulin and potentiates glucose-stimulated somatostatin secretion via cognate receptors on delta cells; islets lacking endogenous Ucn3 have fewer delta cells, reduced somatostatin content, impaired somatostatin secretion, and exaggerated insulin release		immunostaining	van der Meulen et al. (2015)			This is a derived feature. Individual-level signal intensity images were extracted from supplemental files and clustered into Low, Intermediate, and High categories.	Supplemental Figure 7	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496282/bin/NIHMS686747-supplement-1.pdf
PMID26055066	Taniguchi et al. (2015)	Taniguchi15_CCD1.score	CCD1.score	[0-3]	Cyclin D1 expression as % of islet cells stained		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	595						1	1		'0 to 3’=0,’1 to 30%’=1, ‘31 to 60%’=2,’greater than 60%’=3	immunostaining	Taniguchi et al. (2015)				Table 1: The extent of expression of cyclin-D1 and -D3 in islets from heart-beating or post mortem control donors. & Table 2: The extent of expression of cyclin-D1 and -D3 in islets from heart-beating or post mortem autoantibody-positive donors and those with type 1 diabetes.	https://link.springer.com/article/10.1007%2Fs00125-015-3645-1#Tab1|https://link.springer.com/article/10.1007%2Fs00125-015-3645-1#Tab2
PMID26055066	Taniguchi et al. (2015)	Taniguchi15_CCD3.score	CCD3.score	[0-3]	Cyclin D3 expression as % of islet cells stained		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	896						1	1		Coded as 0 to 3: +, 1 to 30%; ++, 31 to 60%; +++, greather than 60%	immunostaining	Taniguchi et al. (2015)				Table 1: The extent of expression of cyclin-D1 and -D3 in islets from heart-beating or post mortem control donors. & Table 2: The extent of expression of cyclin-D1 and -D3 in islets from heart-beating or post mortem autoantibody-positive donors and those with type 1 diabetes.	https://link.springer.com/article/10.1007%2Fs00125-015-3645-1#Tab1|https://link.springer.com/article/10.1007%2Fs00125-015-3645-1#Tab2
PMID25687234	Reddy et al. (2015)	Reddy15_InsNeg.total.islets	InsNeg.total.islets	count			protein	islet of Langerhans	islet of Langerhans	0	1	Yes											immunostaining	Reddy et al. (2015)					
PMID25687234	Reddy et al. (2015)	Reddy15_InsPos.total.islets	InsPos.total.islets	count			protein	islet of Langerhans	islet of Langerhans	0	1	Yes											immunostaining	Reddy et al. (2015)					
PMID25687234	Reddy et al. (2015)	Reddy15_InsNeg.insulitis.islets	InsNeg.insulitis.islets	count			protein	islet of Langerhans	islet of Langerhans	0	1	Yes											immunostaining	Reddy et al. (2015)					
PMID25687234	Reddy et al. (2015)	Reddy15_InsPos.insulitis.islets	InsPos.insulitis.islets	count			protein	islet of Langerhans	islet of Langerhans	0	1	Yes											immunostaining	Reddy et al. (2015)					
PMID25687234	Reddy et al. (2015)	Reddy15_insulitis.islets	insulitis.islets	count			protein	islet of Langerhans	islet of Langerhans	0	1	Yes											immunostaining	Reddy et al. (2015)					
PMID25687234	Reddy et al. (2015)	Reddy15_CD45.cells	CD45.cells	count	Mean number of peri- and intra-islet leucocytes (CD45+) per islet		cell	leukocyte	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis			1	1			immunostaining	Reddy et al. (2015)				Table 3: Mean number of peri- and intra-islet leucocytes and the sum of the two in relation to insulin-positive and -negative islets and the percentage of islets with insulitis in insulin-positive and -negative islets in non-diabetic and diabetic cases.	https://link.springer.com/article/10.1007%2Fs00125-015-3519-6#Tab3
PMID25687234	Reddy et al. (2015)	Reddy15_CD45.cells.periislet	CD45.cells.periislet	count	Mean number of peri-islet leucocytes (CD45+) per islet		cell	leukocyte	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis			1	1			immunostaining	Reddy et al. (2015)				Table 3: Mean number of peri- and intra-islet leucocytes and the sum of the two in relation to insulin-positive and -negative islets and the percentage of islets with insulitis in insulin-positive and -negative islets in non-diabetic and diabetic cases.	https://link.springer.com/article/10.1007%2Fs00125-015-3519-6#Tab3
PMID25687234	Reddy et al. (2015)	Reddy15_CD45.cells.intraislet	CD45.cells.intraislet	count	Mean number of intra-islet leucocytes (CD45+) per islet		cell	leukocyte	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis			1	1			immunostaining	Reddy et al. (2015)				Table 3: Mean number of peri- and intra-islet leucocytes and the sum of the two in relation to insulin-positive and -negative islets and the percentage of islets with insulitis in insulin-positive and -negative islets in non-diabetic and diabetic cases.	https://link.springer.com/article/10.1007%2Fs00125-015-3519-6#Tab3
PMID25687234	Reddy et al. (2015)	Reddy15_InsPos.CD45.cells	InsPos.CD45.cells	count	Mean number of peri- and intra-islet leucocytes (CD45+) per insulin-positive islet		cell	leukocyte	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis			1	1			immunostaining	Reddy et al. (2015)				Table 3: Mean number of peri- and intra-islet leucocytes and the sum of the two in relation to insulin-positive and -negative islets and the percentage of islets with insulitis in insulin-positive and -negative islets in non-diabetic and diabetic cases.	https://link.springer.com/article/10.1007%2Fs00125-015-3519-6#Tab3
PMID25687234	Reddy et al. (2015)	Reddy15_InsNeg.CD45.cells	InsNeg.CD45.cells	count	Mean number of peri- and intra-islet leucocytes (CD45+) per insulin-negative islet		cell	leukocyte	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Reddy et al. (2015)				Table 3: Mean number of peri- and intra-islet leucocytes and the sum of the two in relation to insulin-positive and -negative islets and the percentage of islets with insulitis in insulin-positive and -negative islets in non-diabetic and diabetic cases.	https://link.springer.com/article/10.1007%2Fs00125-015-3519-6#Tab3
PMID25687234	Reddy et al. (2015)	Reddy15_InsPos.CD45.cells.periislet	InsPos.CD45.cells.periislet	count	Mean number of peri-islet leucocytes (CD45+) per insulin-positive islet		cell	leukocyte	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Reddy et al. (2015)				Table 3: Mean number of peri- and intra-islet leucocytes and the sum of the two in relation to insulin-positive and -negative islets and the percentage of islets with insulitis in insulin-positive and -negative islets in non-diabetic and diabetic cases.	https://link.springer.com/article/10.1007%2Fs00125-015-3519-6#Tab3
PMID25687234	Reddy et al. (2015)	Reddy15_InsNeg.CD45.cells.periislet	InsNeg.CD45.cells.periislet	count	Mean number of peri-islet leucocytes (CD45+) per insulin-negative islet		cell	leukocyte	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis			1	1			immunostaining	Reddy et al. (2015)				Table 3: Mean number of peri- and intra-islet leucocytes and the sum of the two in relation to insulin-positive and -negative islets and the percentage of islets with insulitis in insulin-positive and -negative islets in non-diabetic and diabetic cases.	https://link.springer.com/article/10.1007%2Fs00125-015-3519-6#Tab3
PMID25687234	Reddy et al. (2015)	Reddy15_InsPos.CD45.cells.intraislet	InsPos.CD45.cells.intraislet	count	Mean number of intra-islet leucocytes (CD45+) per insulin-positive islet		cell	leukocyte	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis			1	1			immunostaining	Reddy et al. (2015)				Table 3: Mean number of peri- and intra-islet leucocytes and the sum of the two in relation to insulin-positive and -negative islets and the percentage of islets with insulitis in insulin-positive and -negative islets in non-diabetic and diabetic cases.	https://link.springer.com/article/10.1007%2Fs00125-015-3519-6#Tab3
PMID25687234	Reddy et al. (2015)	Reddy15_InsNeg.CD45.cells.intraislet	InsNeg.CD45.cells.intraislet	count	Mean number of intra-islet leucocytes (CD45+) per insulin-negative islet		cell	leukocyte	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Reddy et al. (2015)				Table 3: Mean number of peri- and intra-islet leucocytes and the sum of the two in relation to insulin-positive and -negative islets and the percentage of islets with insulitis in insulin-positive and -negative islets in non-diabetic and diabetic cases.	https://link.springer.com/article/10.1007%2Fs00125-015-3519-6#Tab3
PMID25687234	Reddy et al. (2015)	Reddy15_InsPos.CD45.prct	InsPos.CD45.prct	%	Percent of insulin-positive islets with insulitis (with CD45+ infiltrates)		cell	leukocyte	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Reddy et al. (2015)				Table 3: Mean number of peri- and intra-islet leucocytes and the sum of the two in relation to insulin-positive and -negative islets and the percentage of islets with insulitis in insulin-positive and -negative islets in non-diabetic and diabetic cases.	https://link.springer.com/article/10.1007%2Fs00125-015-3519-6#Tab3
PMID25687234	Reddy et al. (2015)	Reddy15_InsNeg.CD45.prct	InsNeg.CD45.prct	%	Percent of insulin-negative islets with insulitis (with CD45+ infiltrates)		cell	leukocyte	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Reddy et al. (2015)				Table 3: Mean number of peri- and intra-islet leucocytes and the sum of the two in relation to insulin-positive and -negative islets and the percentage of islets with insulitis in insulin-positive and -negative islets in non-diabetic and diabetic cases.	https://link.springer.com/article/10.1007%2Fs00125-015-3519-6#Tab3
PMID25687234	Reddy et al. (2015)	Reddy15_CD45.prct	CD45.prct	%	Percent of islets with insulitis (with CD45+ infiltrates)		cell	leukocyte	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis				NA			immunostaining	Reddy et al. (2015)				Table 3: Mean number of peri- and intra-islet leucocytes and the sum of the two in relation to insulin-positive and -negative islets and the percentage of islets with insulitis in insulin-positive and -negative islets in non-diabetic and diabetic cases.	https://link.springer.com/article/10.1007%2Fs00125-015-3519-6#Tab3
PMID25576800	Harms et al. (2015)	Harms15_IL18.cells	IL18.cells	%	Percent of islets with at least two IL-18+ cells, quantitated in 25 islets per sample		cell	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA						1	1			immunostaining	Harms et al. (2015)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315765/figure/F5/
PMID25576800	Harms et al. (2015)	Harms15_IL18.cells.high	IL18.cells.high	%	Percent of islets with at least five IL-18+ cells, quantitated in 25 islets per sample		cell	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA						1	1			immunostaining	Harms et al. (2015)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315765/figure/F5/
PMID25532042	Grzesik et al. (2014)	Grzesik14_x12LO	x12LO	[Positive,Negative]	Staining for 12LO (positive or negative)		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	239						1	1			immunostaining	Grzesik et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333045/figure/F2/
PMID25532042	Grzesik et al. (2014)	Grzesik14_islet.area	islet.area	%	Islet area as % of pancreas area	islet parameters	tissue	islet of Langerhans	pancreas	0	1	Contact authors	NA		MP:0009166	abnormal pancreatic islet number			1	1			immunostaining	Grzesik et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333045/figure/F2/
PMID25532042	Grzesik et al. (2014)	Grzesik14_beta.area	beta.area	%	Beta cells as % of islet area	beta cell parameters	cell	type B pancreatic cell	pancreas	0	1	Contact authors	NA		MP:0020578	abnormal pancreatic beta cell number			1	1			immunostaining	Grzesik et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333045/figure/F2/
PMID25532042	Grzesik et al. (2014)	Grzesik14_x12LO.pancreas	x12LO.pancreas	%	Expression of 12LO as % of pancreas area		protein	pancreas	pancreas	0	1	Contact authors	NA						1	1			immunostaining	Grzesik et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333045/figure/F2/
PMID25532042	Grzesik et al. (2014)	Grzesik14_x12LO.islet	x12LO.islet	%	Expression of 12LO as % of islet area		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA						1	1			immunostaining	Grzesik et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333045/figure/F2/
PMID25532042	Grzesik et al. (2014)	Grzesik14_x12LO.beta	x12LO.beta	%	Expression of 12LO as % of beta cell area (insulin-positive area)		protein	type B pancreatic cell	islet of Langerhans	0	1	Contact authors	NA						1	1			immunostaining	Grzesik et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333045/figure/F2/
PMID25422108	Krogvold et al. (2014)	VP1 	VP1	[Positive,Negative]	Enterovirus VP1 expression (positive or negative). See note.	viral-related	protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA						1	1			immunostaining	Krogvold et al. (2014)			Included only nondiabetic organ donors from nPOD, used as controls for DiVid cohort. All samples tested negative for VP1.		
PMID25226365	Subauste et al. (2014)	Subauste14_beta.mass	beta.mass	grams	Estimated beta cell mass		cell	type B pancreatic cell	islet of Langerhans	0	1	Contact authors	NA						1	1			immunostaining	Subauste et al. (2014)	Insulin stained area was quantified with ImageProplus (Media Cybernetics, Rockville, MD) and expressed as ratio to the total pancreatic area. The average ratio between insulin stained area and total areas was multiplied by the pancreatic weight in gms thus yielding the estimated BCM in gms.				
PMID25077543	Piran et al. (2014)	Piran14_delta2alpha	delta2alpha	somatostatin+ area/glucagon+ area	Delta to alpha cell ratio		cell	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA						1	1			immunostaining	Piran et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123101/figure/fig6/
PMID24947367	Rodriguez-Calvo et al. (2014)	RodriguezCalvo14_CD8.cells	CD8.cells	CD8+ cells/mm^2	Mean CD8+ cell infiltration reported as mean density values		cell	CD8-positive, alpha-beta T cell	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis			1	1			immunostaining	Rodriguez-Calvo et al. (2014)	An average of 10 to 15 stained images (surface area of 1.215 mm2) from each tissue section acquired and analysis was performed using a custom macro developed in MATLAB and ImageJ. islet regions were identified as contiguous areas of insulin or glucagon staining at or above a threshold intensity value. CD8+ cells were identified as areas of CD8 staining using optimized and identical threshold values for intensity and size for all the images. A comparison between manual counts and software-assisted counts was performed in 15 images in order to validate the macro used to quantify CD8+ cells.				https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207385/bin/supp_db14-0549_DB140549SupplementaryData.pdf
PMID24947367	Rodriguez-Calvo et al. (2014)	RodriguezCalvo14_CD4.cells	CD4.cells	CD4+ cells/mm^2	Mean CD4+ cell infiltration reported as mean density values		cell	CD4-positive, alpha-beta T cell	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis			1	1			immunostaining	Rodriguez-Calvo et al. (2014)	For CD4 five images from each donor were analyzed manually.				https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207385/bin/supp_db14-0549_DB140549SupplementaryData.pdf
PMID24947367	Rodriguez-Calvo et al. (2014)	RodriguezCalvo14_CD11c.cells	CD11c.cells	CD11c+ cells/mm^2	Mean immune cell infiltration reported as mean density values		cell	dendritic cell	islet of Langerhans	0	1	Yes	NA						1	1			immunostaining	Rodriguez-Calvo et al. (2014)	For CD11c five images from each donor were analyzed manually.				https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207385/bin/supp_db14-0549_DB140549SupplementaryData.pdf
PMID24939426	Arif et al. (2014)	Arif14_CD20.cat	CD20.cat	[Lo,Hi]	Mean CD20+ cells (cells stained per islet) and categorized into CD20Hi or CD20Lo; only for islets with residual immune staining for insulin	leukocyte infiltration	cell	B cell	islet of Langerhans	0	1	Contact authors	NA		MP:0004031	insulitis			1	1			immunostaining	Arif et al. (2014)	CD20 staining was used to subdivide 21 patients into CD20Hi and CD20Lo categories by using mean CD20+ cell counts above (CD20Hi) and below (CD20Lo) 3.7 cells/islet.			Figure 4: Immunohistological analysis of pancreas from patients with type 1 diabetes reveals heterogeneity of insulitis.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207393/figure/F4/
PMID24939426	Arif et al. (2014)	Arif14_CD8.cells	CD8.cells	cells/islet	Mean CD8+ cells (cells stained per islet); only for islets with residual immune staining for insulin		cell	CD8-positive, alpha-beta T cell	islet of Langerhans	0	1	Contact authors	NA		MP:0004031	insulitis				NA			immunostaining	Arif et al. (2014)					
PMID24939426	Arif et al. (2014)	Arif14_CD68.cells	CD68.cells	cells/islet	Mean CD68+ cells (cells stained per islet); only for islets with residual immune staining for insulin		cell	macrophage	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Arif et al. (2014)					
PMID24939426	Arif et al. (2014)	Arif14_CD4.cells	CD4.cells	cells/islet	Mean CD4+ cells (cells stained per islet); only for islets with residual immune staining for insulin		cell	CD4-positive, alpha-beta T cell	islet of Langerhans	0	1	Contact authors	NA		MP:0004031	insulitis				NA			immunostaining	Arif et al. (2014)					
PMID24677718	Bogdani et al. (2014)	Bogdani14_Hyaluronan.islet	Hyaluronan.islet	HA+ area/mm^2	Hyaluronan-positive area in peri- and intra-islet		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							1			immunostaining	Bogdani et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113060/figure/F2/
PMID24677718	Bogdani et al. (2014)	Bogdani14_Hyaluronan.follicle	Hyaluronan.follicle	%	Hyaluronan-positive area in splenic B cell follicles		protein	spleen lymphoid follicle	spleen	0	1	Contact authors	NA							1			immunostaining	Bogdani et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113060/figure/F6/
PMID24677718	Bogdani et al. (2014)	Bogdani14_Hyaluronan.spleen	Hyaluronan.spleen	%	Hyaluronan-positive area in splenic T cell area		protein	other	spleen	0	1	Contact authors	NA							1			immunostaining	Bogdani et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113060/figure/F6/
PMID24677718	Bogdani et al. (2014)	Bogdani14_Hyaluronan.PLN	Hyaluronan.PLN	%	Hyaluronan-positive area in pancreatic lymph node (PLN) tissue area		protein	pancreatic lymph node	pancreatic lymph node	0	1	Contact authors	NA							1			immunostaining	Bogdani et al. (2014)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113060/figure/F6/
PMID24677718	Bogdani et al. (2014)	Bogdani14_IalphaI	IalphaI		Characterization of hyaluronan-binding protein		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Bogdani et al. (2014)					
PMID24677718	Bogdani et al. (2014)	Bogdani14_Versican	Versican		Characterization of hyaluronan-binding protein		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Bogdani et al. (2014)					
PMID24677718	Bogdani et al. (2014)	Bogdani14_TSG6	TSG6		Characterization of hyaluronan-binding protein		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Bogdani et al. (2014)					
PMID24498006	Ye et al. (2014)	Ye14_MMc.cells	Mmc.cells	total no. MMc/total cells (%)	Maternal microchimeric cell quantification in pancreas	maternal microchimerism	cell	other	pancreas	0	1	Yes	NA		http://purl.bioontology.org/ontology/MESH/D046528	chimerism				1			immunostaining	Ye et al. (2014)				Table 2: Frequencies of MMc in T1D and control male human pancreases.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909047/table/pone-0086985-t002/
PMID24498006	Ye et al. (2014)	Ye14_Ins.MMc.cells	Ins.Mmc.cells	no. of insulin+ MMc/total cells (%)	Enrichment of MMcs in the beta cell fraction	maternal microchimerism	cell	type B pancreatic cell	islet of Langerhans	0	1	Yes	NA							1			immunostaining	Ye et al. (2014)				Table 2: Frequencies of MMc in T1D and control male human pancreases.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909047/table/pone-0086985-t002/
PMID24264405	Yip et al. (2013)	Yip13_Adora1	Adora1		Expression of adenosine A1 receptor (Adora1) by staining; no quantification		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Yip et al. (2013)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837064/figure/F3/
PMID24264405	Yip et al. (2013)	Yip13_ADORA1.var	ADORA1.var		Presence of a Adora1 variant assessed by RT-PCR		genotype	islet of Langerhans	islet of Langerhans	0	1	Yes	134							NA			immunostaining	Yip et al. (2013)				Fig 4: An alternatively spliced isoform of Adora1 is expressed in the pancreas of NOD and AA+ patients.	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837064/figure/F4/
PMID23920110	Kavishwar et al. (2013)	Kavishwar13_sphingo.score	sphingo.score	staining intensity score	Quantification of sphingomyelin (SM) patches as IC2-antibody staining intensity		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0009823	abnormal sphingomyelin level				NA			immunostaining	Kavishwar et al. (2013)				Table 1	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840740/table/table1-0022155413502792/
PMID23920110	Kavishwar et al. (2013)	Kavishwar13_Ins.score	Ins.score	staining intensity score	Staining for Insulin		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Kavishwar et al. (2013)				Table 1	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840740/table/table1-0022155413502792/
PMID23920110	Kavishwar et al. (2013)	Kavishwar13_Gcg.score	Gcg.score	staining intensity score	Staining for Glucagon		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA							NA			immunostaining	Kavishwar et al. (2013)				Table 1	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840740/table/table1-0022155413502792/
PMID23904478	Chen et al. (2013)	Chen13_IL15	IL15	normalized expression	Expression of IL-15 mRNA reported as normalized counts to three housekeeping genes		transcript	islet of Langerhans	islet of Langerhans	0	1	Individual-level data not available	NA						0	1			immunostaining	Chen et al. (2013)			Individual-level data is not available.		https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746870/figure/fig06/
PMID23904478	Chen et al. (2013)	Chen13_IL15Ra	IL15Ra	normalized expression	Expression of IL-15Ralpha reported as normalized counts to three housekeeping genes		transcript	islet of Langerhans	islet of Langerhans	0	1	Individual-level data not available	NA						0	1			immunostaining	Chen et al. (2013)			Individual-level data is not available.		https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746870/figure/fig06/
PMID23904478	Chen et al. (2013)	Chen13_MxA.pos	MxA.pos	[0,1]	Positive for expression of MxA (a GTPase induced by type 1 IFN) as detected by staining		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	4599						0	1			immunostaining	Chen et al. (2013)		In text: Immunohistochemistry demonstrated IL-15 expression in the islets in all T1D patients examined (four out of four, nPOD-6038, nPOD-6046, nPOD-6050, and nPOD-6084), whereas IL-15 was detected only in the pancreatic islets in one out of four normal donors and two out of five autoantibody positive donors (Fig. 6A). Interestingly, in two cases where IL-15 was positive, we also detected islet expression of MxA, a GTPase induced by type 1 IFN (?/?), that has been reported to interfere with virus multiplication and spread (28) (Fig. S6).	Data values are mentioned in publication text.	"Fig S6: Increased expression of MxA in the islets of a patient with type 1 diabetes [Network for Pancreatic Organ Donors (nPOD)-6084] and an autoantibody
positive donor (nPOD-6023)."	http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1312911110/-/DCSupplemental/pnas.201312911SI.pdf?targetid=nameddest=SF6
PMID23139348	Korpos et al. (2012)	Korpos12_BM.pos	BM.pos	[0,1]	Normal/intact extracellular matrix (ECM) composition based on staining for basement membrane (BM) components; pan-laminin, collagen, perlecan, agrin, nidogen1/2		tissue	pancreas	pancreas	0	1	Yes	NA		MP:0004272	abnormal basement membrane morphology			1	1		1 = intact; 0 = no staining in some areas	immunostaining	Korpos et al. (2012)				Supplementary Table 2: Summary of analyzed nPOD samples.	http://diabetes.diabetesjournals.org/highwire/filestream/72250/field_highwire_adjunct_files/0/DB120432SupplementaryData.pdf
PMID23139348	Korpos et al. (2012)	Korpos12_IM.pos	IM.pos	[0,1]	Normal/intact extracellular matrix (ECM) composition based on staining for interstitial matrix (IM) components; collagen, fibronectin, tenascin-C, matrillin, fibrillin		tissue	pancreas	pancreas	0	1	Yes	NA		MP:0013258	abnormal extracellular matrix morphology			0	0		1 = intact; 0 = no staining in some areas	immunostaining	Korpos et al. (2012)				Supplementary Table 2: Summary of analyzed nPOD samples.	http://diabetes.diabetesjournals.org/highwire/filestream/72250/field_highwire_adjunct_files/0/DB120432SupplementaryData.pdf
PMID23064357	Richardson et al. (2012)	Richardson12_VP1	VP1	Count	Enterovirus VP1 expression as # Insulin-containing islets (ICIs) with multiple VP1+ cells	viral-related	protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0020163	increased susceptibility to virus induced diabetes			1	1			immunohistochemistry	Richardson et al. (2012)				Table 1: nPOD type 1 diabetes patients and non-diabetic controls.	https://link.springer.com/article/10.1007%2Fs00125-012-2745-4#Tab1
PMID23064357	Richardson et al. (2012)	Richardson12_ICI	ICI	Count	Count of insulin-containing islets		cell	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0020578	abnormal pancreatic beta cell number				NA			immunohistochemistry	Richardson et al. (2012)				Table 1: nPOD type 1 diabetes patients and non-diabetic controls.	https://link.springer.com/article/10.1007%2Fs00125-012-2745-4#Tab1
PMID23064357	Richardson et al. (2012)	Richardson12_VP1.ICI	VP1.ICI	%	Enterovirus VP1 expression as percent of insulin-containing islets with multiple VP1+ cells (VP1/ICI)	viral-related	phenotype	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0020163	increased susceptibility to virus induced diabetes				NA			immunohistochemistry	Richardson et al. (2012)			This is a derived feature. See VP1 and ICI.	Table 1: nPOD type 1 diabetes patients and non-diabetic controls.	https://link.springer.com/article/10.1007%2Fs00125-012-2745-4#Tab1
PMID22923498	Yip et al. (2012)	Yip12_EIF4G3	EIF4G3	expression relative to housekeeping gene (beta-actin) x10E-6	EIF4G3 mRNA expression		transcript	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA						0	1			immunostaining	Yip et al. (2012)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604916/figure/MJS052F2/
PMID22923498	Yip et al. (2012)	Yip12_EIF4G1	EIF4G1	expression relative to housekeeping gene (GAPDH) x10E-3	EIF4G1 mRNA expression		transcript	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA						0	0			immunostaining	Yip et al. (2012)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604916/figure/MJS052F2/
PMID22745242	Gregg et al. (2012)	Gregg12_islet.diameter	islet.diameter	micrometer (uM)	Average islet diameter		tissue	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA		MP:0009170	abnormal pancreatic islet size				NA			immunostaining	Gregg et al. (2012)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431572/bin/supp_jc.2012-1206_12-1206_supp_data.pdf
PMID22745242	Gregg et al. (2012)	Gregg12_beta2alpha	beta2alpha	ratio	Beta cell to alpha cell ratio		cell	type B pancreatic cell|pancreatic A cell	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Gregg et al. (2012)	The numbers of insulin-positive beta-cells and glucagon-positive a-cells were counted and the islet b-cell to a-cell ratio calculated, with at least 10 islets analyzed per section.				https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431572/figure/F1/
PMID22745242	Gregg et al. (2012)	Gregg12_beta2delta	beta2delta	ratio	Beta cell to delta cell ratio		cell	type B pancreatic cell|pancreatic ductal cell	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Gregg et al. (2012)	The numbers of insulin-positive b-cells and somatostatin-positive d-cells were counted and the islet b-cell to d-cell ratio calculated, with at least 10 islets analyzed per section.				https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431572/figure/F2/
PMID22745242	Gregg et al. (2012)	Gregg12_prox.neurons	prox.neurons	micrometer (uM)	Distance of a Tuj1-positive neuron from an islet cluster		cell	peripheral nervous system neuron	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Gregg et al. (2012)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431572/figure/F3/
PMID22745242	Gregg et al. (2012)	Gregg12_CK19.Ins.duct	CK19.Ins.duct	% Ins+/CK-19+ cells and insulin+ cells associated in pancreatic ducts	Beta cell neogenesis from ductal cells reported as percentage insulin+/CK-19+ cells and insulin+ cells associated in pancreatic ducts		cell	type B pancreatic cell	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Gregg et al. (2012)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431572/figure/F4/
PMID22745242	Gregg et al. (2012)	Gregg12_Ki67.Ins	Ki67.Ins	% Ins+ cells	Beta cell proliferation measured as insulin+/Ki67+ cells as a percentage of all insulin-positive cells in each section		cell	type B pancreatic cell	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Gregg et al. (2012)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431572/figure/F5/
PMID22745242	Gregg et al. (2012)	Gregg12_CK19.Ins	CK19.Ins	% CK-19+ cells	Ductal cell proliferation measured as CK-19+/Ki67+ cells as a percentage of all CK-19-positive cells in each section		cell	pancreatic ductal cell	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Gregg et al. (2012)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431572/figure/F6/
PMID22699564	Marhfour et al. (2012)	Marhfour12_CHOP	CHOP		CHOP immunostaining intensity	ER	protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Marhfour et al. (2012)					https://media.springernature.com/original/springer-static/image/art%3A10.1007%2Fs00125-012-2604-3/MediaObjects/125_2012_2604_Fig2_HTML.gif
PMID22699564	Marhfour et al. (2012)	Marhfour12_BIP	BIP		BIP immunostaining intensity	ER	protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Marhfour et al. (2012)					https://media.springernature.com/original/springer-static/image/art%3A10.1007%2Fs00125-012-2604-3/MediaObjects/125_2012_2604_Fig2_HTML.gif
PMID22699564	Marhfour et al. (2012)	Marhfour12_XBP1	XBP1		XBP-1 immunostaining intensity	ER	protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA							NA			immunostaining	Marhfour et al. (2012)					https://media.springernature.com/original/springer-static/image/art%3A10.1007%2Fs00125-012-2604-3/MediaObjects/125_2012_2604_Fig2_HTML.gif
PMID22213807	Coppieters et al. (2012)	Coppieters12_Ins.score	Ins.score	[Normal,Decreased,Negative]	Insulin expression, category		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0009255	degranulated pancreatic beta cells			1	1		insulin: ++, normal numbers of insulin-sufficient islets, in excess of 50 per section; +, decreased numbers (<50; average insulin + islet size reduced);  -, negative	immunostaining	Coppieters et al. (2012)				Table S1: Insulin, CD8, and HLA Class I expression patterns within pancreatic islets from diabetic individuals and controls	http://jem.rupress.org/highwire/filestream/102893/field_highwire_adjunct_files/0/JEM_20111187_sm.pdf
PMID22213807	Coppieters et al. (2012)	Coppieters12_MHCI.score	MHCI.score	[Negative,Positive]	MHC Class I expression, category		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0001836	abnormal antigen presentation via MHC class I			0	0		MHC I: -, negative, based on nondiabetic controls, normal expression approximates three positive nonendocrine cells; +, positive.	immunostaining	Coppieters et al. (2012)				Table S1: Insulin, CD8, and HLA Class I expression patterns within pancreatic islets from diabetic individuals and controls	http://jem.rupress.org/highwire/filestream/102893/field_highwire_adjunct_files/0/JEM_20111187_sm.pdf
PMID22213807	Coppieters et al. (2012)	Coppieters12_CD8.score	CD8.score	[Normal,High]	Islet CD8 expression, category		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0004031	insulitis			0	0		Islet CD8: normal, less than five per islet; +, accumulation of more than five cells per islet	immunostaining	Coppieters et al. (2012)	In situ tetramer staining			Table S1: Insulin, CD8, and HLA Class I expression patterns within pancreatic islets from diabetic individuals and controls	http://jem.rupress.org/highwire/filestream/102893/field_highwire_adjunct_files/0/JEM_20111187_sm.pdf
PMID22210319	Sarkar et al. (2012)	Sarkar12_CCL5	CCL5	NA	Expression assessed through IHC		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA		MP:0008713	abnormal cytokine level	EFO:0005117	CCL5 measurement		1			immunohistochemistry	Sarkar et al. (2012)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266427/figure/F6/
PMID22210319	Sarkar et al. (2012)	Sarkar12_CCL8	CCL8	NA	Expression assessed through IHC		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA		MP:0008713	abnormal cytokine level	EFO:0004873	cytokine measurement		1			immunohistochemistry	Sarkar et al. (2012)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266427/figure/F6/
PMID22210319	Sarkar et al. (2012)	Sarkar12_CXCL9	CXCL9	NA	Expression assessed through IHC		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA		MP:0008713	abnormal cytokine level	EFO:0004873	cytokine measurement		1			immunohistochemistry	Sarkar et al. (2012)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266427/figure/F6/
PMID22210319	Sarkar et al. (2012)	Sarkar12_CX3CL1	CX3CL1	NA	Expression assessed through IHC		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA		MP:0008713	abnormal cytokine level	EFO:0004873	cytokine measurement		1			immunohistochemistry	Sarkar et al. (2012)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266427/figure/F6/
PMID22210319	Sarkar et al. (2012)	Sarkar12_CXCL10	CXCL10	NA	Expression assessed through IHC		protein	islet of Langerhans	islet of Langerhans	0	1	Contact authors	NA		MP:0008713	abnormal cytokine level	EFO:0004873	cytokine measurement		1			immunohistochemistry	Sarkar et al. (2012)					https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266427/figure/F7/
PMID20062967	Gianani et al. (2010)	Gianani10_Ins.pos	Ins.pos	[0,1]	Insulin+ islets observed		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0020578	abnormal pancreatic beta cell number			1	1			immunohistochemistry	Gianani et al. (2010)				Table 1: Demographic information and characteristics as shown in the 20 childhood-onset diabetic patients analysed.	https://link.springer.com/article/10.1007%2Fs00125-009-1642-y#Tab1
PMID20062967	Gianani et al. (2010)	Gianani10_HLA.pos	HLA.pos	[0,1]	Class I HLA+ expression observed	HLA	protein	islet of Langerhans	islet of Langerhans	0	1	Yes	NA		MP:0001836	abnormal antigen presentation via MHC class I			1	1			immunohistochemistry	Gianani et al. (2010)				Table 1: Demographic information and characteristics as shown in the 20 childhood-onset diabetic patients analysed.	https://link.springer.com/article/10.1007%2Fs00125-009-1642-y#Tab1
PMID20062967	Gianani et al. (2010)	Gianani10_Survivin.pos	Survivin.pos	[0,1]	Survivin+ beta expression observed		protein	islet of Langerhans	islet of Langerhans	0	1	Yes	332						1	1			immunohistochemistry	Gianani et al. (2010)				Table 1: Demographic information and characteristics as shown in the 20 childhood-onset diabetic patients analysed.	https://link.springer.com/article/10.1007%2Fs00125-009-1642-y#Tab1
Aab		GADA.pos	GADA.pos		Autoantibody-positive for GADA		phenotype			0	1	Yes	NA		MP:0001844	autoimmune response	EFO:0004866	autoantibody measurement		NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / AutoAb Results	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5045
Aab		IA2A.pos	IA2A.pos		Autoantibody-positive for IA2A		phenotype			0	1	Yes	NA		MP:0001844	autoimmune response	EFO:0004866	autoantibody measurement		NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / AutoAb Results	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5045
Aab		mIAA.pos	mIAA.pos		Autoantibody-positive for mIAA		phenotype			0	1	Yes	NA		MP:0001844	autoimmune response	EFO:0004866	autoantibody measurement		NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / AutoAb Results	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5045
Aab		Znt8A.pos	Znt8A.pos		Autoantibody-positive for Znt8A		phenotype			0	1	Yes	NA		MP:0001844	autoimmune response	EFO:0004866	autoantibody measurement		NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / AutoAb Results	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5045
Aab		AutoAb.count	AutoAb.count	count	Count of autoantibody types detected		phenotype			0	1	Yes	NA		MP:0001844	autoimmune response	EFO:0004866	autoantibody measurement		NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / AutoAb Results	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5045
Demographics		age	age	yrs	Age	demographic	phenotype			0	1	Yes	NA			demographic	EFO:0008007	age at assessment		NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / Demographics	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5001
Demographics		gender	gender		Sex	demographic	phenotype			0	1	Yes	NA			demographic				NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / Demographics	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5001
Demographics		ethnic.grp	ethnic.grp		Race	demographic	phenotype			0	1	Yes	NA			demographic				NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / Demographics	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5001
Demographics		cause.death.cat	cause.death.cat		Cause of death	clinical	phenotype			0	1	Yes	NA							NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / Demographics	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5001
Demographics		height	height	m	Height	clinical	phenotype			0	1	Yes	NA				EFO:0004339	body height		NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / Demographics	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5001
Demographics		weight	weight	kg	Weight	clinical	phenotype			0	1	Yes	NA				EFO:0004338	body weight		NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / Demographics	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5001
Demographics		BMI	BMI	kg/m2	Body Mass Index	clinical	phenotype			0	1	Yes	NA				EFO:0004995	body mass index		NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / Demographics	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5001
Demographics		ABO.grp	ABO.grp		ABO blood group	clinical	phenotype			0	1	Yes	NA							NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / Demographics	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5001
DiabetesInfo		db.duration	db.duration	yrs	Diabetes duration	clinical	clinical			0	1	Yes	NA				EFO:0000433	duration		NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / Diabetes Info	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5008
DiabetesInfo		age.onset	age.onset	yrs	Age at disease onset	clinical	phenotype			0	1	Yes	NA				EFO:0004847	age at onset		NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / Diabetes Info	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5008
DiabetesInfo		Cpeptide	Cpeptide	ng/ml	C-peptide	clinical	phenotype			0	1	Yes	NA		MP:0003564	abnormal insulin secretion	EFO:0005187	C-peptide measurement		NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / Diabetes Info	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5008
DiabetesInfo		HbA1c	HbA1c	%	HbA1c	clinical	phenotype			0	1	Yes	NA		MP:0000188	abnormal circulating glucose level	EFO:0004541	A1C measurement		NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / Diabetes Info	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5008
DiabetesInfo		peak.gluc	peak.gluc	mg/dl	Peak glucose	clinical	phenotype			0	1	Yes	NA		MP:0002078	abnormal glucose homeostasis	EFO:0004468	glucose measurement		NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / Diabetes Info	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5008
DiabetesInfo		donor.type	donor.type		Donor type	clinical	phenotype			0	1	Yes	NA							NA				nPODCore			An investigator account is required for accessing data.	nPOD DataShare / Diabetes Info	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5008
Histopathology		Ins	Ins				phenotype	pancreas	pancreas	0	1	Yes	NA		MP:0020578	abnormal pancreatic beta cell number				NA				nPODCore			An investigator account is required for accessing data. This is a derived feature, i.e. extracted from text reports.	nPOD DataShare / Histopathology	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5011
Histopathology		amyloid	amyloid				phenotype	pancreas	pancreas	0	1	Yes	NA		MP:0000604	amyloidosis	EFO:0008351	amyloid deposition measurement		NA				nPODCore			An investigator account is required for accessing data. This is a derived feature, i.e. extracted from text reports.	nPOD DataShare / Histopathology	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5011
Histopathology		dysplasia	dysplasia				phenotype	pancreas	pancreas	0	1	Yes	NA		MP:0001944	abnormal pancreas morphology				NA				nPODCore			An investigator account is required for accessing data. This is a derived feature, i.e. extracted from text reports.	nPOD DataShare / Histopathology	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5011
Histopathology		metaplasia	metaplasia				phenotype	pancreas	pancreas	0	1	Yes	NA		MP:0013221	pancreatic acinar-to-ductal metaplasia				NA				nPODCore			An investigator account is required for accessing data. This is a derived feature, i.e. extracted from text reports.	nPOD DataShare / Histopathology	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5011
Histopathology		pancreatitis	pancreatitis				phenotype	pancreas	pancreas	0	1	Yes	NA		MP:0001869	pancreas inflammation	EFO:0000278	pancreatitis		NA				nPODCore			An investigator account is required for accessing data. This is a derived feature, i.e. extracted from text reports.	nPOD DataShare / Histopathology	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5011
Histopathology		atrophy	atrophy				phenotype	pancreas	pancreas	0	1	Yes	NA		MP:0009164	exocrine pancreas atrophy				NA				nPODCore			An investigator account is required for accessing data. This is a derived feature, i.e. extracted from text reports.	nPOD DataShare / Histopathology	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5011
Histopathology		fibrosis	fibrosis				phenotype	pancreas	pancreas	0	1	Yes	NA		MP:0003334	pancreas fibrosis				NA				nPODCore			An investigator account is required for accessing data. This is a derived feature, i.e. extracted from text reports.	nPOD DataShare / Histopathology	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5011
Histopathology		CD3	CD3				phenotype	pancreas	pancreas	0	1	Yes	NA		MP:0004031	insulitis				NA				nPODCore			An investigator account is required for accessing data. This is a derived feature, i.e. extracted from text reports.	nPOD DataShare / Histopathology	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5011
Histopathology		Ki67	Ki67				phenotype	pancreas	pancreas	0	1	Yes	NA		MP:0005518	abnormal pancreas regeneration				NA				nPODCore			An investigator account is required for accessing data. This is a derived feature, i.e. extracted from text reports.	nPOD DataShare / Histopathology	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5011
Histopathology		islet.freq	islet.freq				phenotype	islet of Langerhans	pancreas	0	1	Yes	NA		MP:0009166	abnormal pancreatic islet number				NA				nPODCore			An investigator account is required for accessing data. This is a derived feature, i.e. extracted from text reports.	nPOD DataShare / Histopathology	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5011
Histopathology		islet.size	islet.size				phenotype	islet of Langerhans	pancreas	0	1	Yes	NA		MP:0009170	abnormal pancreatic islet size				NA				nPODCore			An investigator account is required for accessing data. This is a derived feature, i.e. extracted from text reports.	nPOD DataShare / Histopathology	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5011
HLAPhased		A.1	A.1		HLA-A allele	HLA	genotype			0	1	Yes	NA			genetic risk	EFO:0000513	genotype		NA				KaddisLab			An investigator account is required for accessing data. Unlike original data, alleles have been phased.	nPOD DataShare / Hi-Res HLA	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5029
HLAPhased		B.1	B.1		HLA-B allele	HLA	genotype			0	1	Yes	NA			genetic risk	EFO:0000513	genotype		NA				KaddisLab			An investigator account is required for accessing data. Unlike original data, alleles have been phased.	nPOD DataShare / Hi-Res HLA	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5029
HLAPhased		C.1	C.1		HLA-C allele	HLA	genotype			0	1	Yes	NA			genetic risk	EFO:0000513	genotype		NA				KaddisLab			An investigator account is required for accessing data. Unlike original data, alleles have been phased.	nPOD DataShare / Hi-Res HLA	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5029
HLAPhased		A.2	A.2		HLA-A allele	HLA	genotype			0	1	Yes	NA			genetic risk	EFO:0000513	genotype		NA				KaddisLab			An investigator account is required for accessing data. Unlike original data, alleles have been phased.	nPOD DataShare / Hi-Res HLA	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5029
HLAPhased		B.2	B.2		HLA-B allele	HLA	genotype			0	1	Yes	NA			genetic risk	EFO:0000513	genotype		NA				KaddisLab			An investigator account is required for accessing data. Unlike original data, alleles have been phased.	nPOD DataShare / Hi-Res HLA	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5029
HLAPhased		C.2	C.2		HLA-C allele	HLA	genotype			0	1	Yes	NA			genetic risk	EFO:0000513	genotype		NA				KaddisLab			An investigator account is required for accessing data. Unlike original data, alleles have been phased.	nPOD DataShare / Hi-Res HLA	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5029
HLAPhased		DRB1.1	DRB1.1		DRB1 allele	HLA	genotype			0	1	Yes	NA			genetic risk	EFO:0000513	genotype		NA				KaddisLab			An investigator account is required for accessing data. Unlike original data, alleles have been phased.	nPOD DataShare / Hi-Res HLA	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5029
HLAPhased		DRB1.2	DRB1.2		DQA1 allele	HLA	genotype			0	1	Yes	NA			genetic risk	EFO:0000513	genotype		NA				KaddisLab			An investigator account is required for accessing data. Unlike original data, alleles have been phased.	nPOD DataShare / Hi-Res HLA	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5029
HLAPhased		DQA1.1	DQA1.1		DQB1 allele	HLA	genotype			0	1	Yes	NA			genetic risk	EFO:0000513	genotype		NA				KaddisLab			An investigator account is required for accessing data. Unlike original data, alleles have been phased.	nPOD DataShare / Hi-Res HLA	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5029
HLAPhased		DQA1.2	DQA1.2		DRB1 allele	HLA	genotype			0	1	Yes	NA			genetic risk	EFO:0000513	genotype		NA				KaddisLab			An investigator account is required for accessing data. Unlike original data, alleles have been phased.	nPOD DataShare / Hi-Res HLA	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5029
HLAPhased		DQB1.1	DQB1.1		DQA1 allele	HLA	genotype			0	1	Yes	NA			genetic risk	EFO:0000513	genotype		NA				KaddisLab			An investigator account is required for accessing data. Unlike original data, alleles have been phased.	nPOD DataShare / Hi-Res HLA	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5029
HLAPhased		DQB1.2	DQB1.2		DQB1 allele	HLA	genotype			0	1	Yes	NA			genetic risk	EFO:0000513	genotype		NA				KaddisLab			An investigator account is required for accessing data. Unlike original data, alleles have been phased.	nPOD DataShare / Hi-Res HLA	https://npoddatashare.coh.org/labkey/study/nPOD%20DataShare/dataset.view?datasetId=5029
HLARisk		riskII	riskII		DR/DQ risk group – see notes	HLA	genotype			0	1	Yes	NA			genetic risk	EFO:0003919	risk factor		NA				KaddisLab					
HLARisk		riskII.conservative	riskII.conservative							0	1	Yes	NA											KaddisLab					
HLARisk		max.pair.freq	max.pair.freq							0	1	Yes	NA											KaddisLab					
GSE72492	Yip et al. (unpublished)	Transcriptomics	Transcriptomics	log2 normalized expression	Transcriptomics data		transcript	pancreas	pancreas	1	2000	Yes	NA							NA			microarray		Agilent-028004 SurePrint G3 Human GE 8x60K Microarray			Series GSE72492: Gene expression in the pancreas of healthy control, auto-antibody positive, and type 1 diabetic subjects	https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72492
